Global Opportunity | Healthcare - Private Patients

Global Opportunity Private Patients 2016

|

Editorial

COVER IMAGE: CHRIS DORNEY/SHUTTERSTOCK.COM

Welcome to Global Opportunity Private Patients 2016 Features Writer Jack Ball jack@inspirepublishing.co.uk Art Editor Nadia Nelson nadia@inspirepublishing.co.uk Production Coordinator Tilly Wade tilly@inspirepublishing.co.uk Creative Director Oscar Bowring oscar@inspirepublishing.co.uk Head of Development Karen Frieze karen@inspirepublishing.co.uk

Printed in the UK by Buxton Press Limited, Palace Road, Buxton, Derbyshire SK17 6AE www.buxtonpress.com

Published by Inspire Publishing 23 Grafton Street London W1S 4EY United Kingdom T: 020 7824 1927 © Inspire Publishing All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise without prior written permission of Inspire Publishing.

Information carried in this publication is checked for accuracy but the views or opinions do not necessarily represent those of Inspire Publishing.

It is for information purposes only and Inspire Publishing does not endorse any of the companies, products or services contained within.

globalopportunityhealthcare.com

IMAGE: ROBERT GRESHOFF

Editor-in-Chief Sarah Cartledge sarah@inspirepublishing.co.uk

Global Opportunity Healthcare has, for the last three years, been at the forefront of Healthcare UK’s promotion of UK expertise in the healthcare sector. It seeks to shed light on all that the country has to offer in the international private patient market – from world leading research and clinical innovations to the latest medical advancements offering the best treatment pathways.

In addition to some of the country’s leading private healthcare offerings, there remains one central pillar to the UK’s healthcare sector. The NHS is the largest publicly funded healthcare system globally, providing care for more than 64.6 million people and employing more than 1.5 million – one of the top five largest workforces in the world.

However, it is no secret that the organisation faces some of the tightest fiscal constraints since its inception. At the same time, demand for high level specialist private care continues to rise, bringing with it much needed revenue potential to support and strengthen NHS services. Housing many of the country’s internationally renowned consultants and support staff, some leading Trusts are uniquely positioned to drive forward their private patient offering – separate facilities set apart from NHS provisioned beds but supported and maintained by world class NHS clinicians.

Thus, working side by side and sometimes in partnership, the private and public arms of the country’s healthcare sector are by no means mutually exclusive. Hospitals such as The Christie in Manchester (see pg 56) have both an NHS hospital and a private oncology clinic, offering patients at home and abroad the widest choice in cancer care.

Some hospitals and providers, in contrast, are looking at how to access international markets. Many of them have chosen to operate in partnership with already established providers, pooling knowledge and resources to maximise their offerings.

Equally, they are identifying how to increase

their share of private patients looking for healthcare from abroad. Clinical excellence is already a given, but international standards of care and relevant support services are areas that some hospitals, clinics and trusts may need to upgrade in order to provide the quality that patients from overseas have come to expect.

Whatever the demand, the UK is uniquely positioned to play a leading role in the development of 21st century global healthcare.

So do use this publication as a valuable insight into the UK private healthcare market.

Further information on areas of opportunity and strength for the UK in the global healthcare market more generally can be found in the latest edition of Global Opportunity Healthcare, launched at Arab Health 2017 in partnership with Healthcare UK.

Sarah Cartledge Editor Global Opportunity Private Patients 2016

Issue 01

Some hospitals and providers, in contrast, are looking at how to access international markets. Many of them have chosen to operate in partnership with already established providers, pooling knowledge and resources to maximise their offerings.’

| Global Opportunity Healthcare Private Patients 2016

3

Global Opportunity Private Patients 2016

|

Contents

Contents

026 1 08 Medical Chambers: Joining the dots

|

Ensuring rapid diagnoses and specialist treatment from some of the world’s leading consultants is the name of the game at 108 Medical Chambers on Harley Street, as Managing Director Hamish Millar, and Chairman of the MAC (Medical Advisory Committee) and Leading Consultant, Simon Marsh tells Jack Ball

030 A dvanced Oncotherapy: Beaming into the future Advanced Oncotherapy’s newest clinic in Harley Street will serve as a benchmark for cancer radiotherapy treatment with their next generation of proton beam therapy technology, as Dr Mike Sinclair, Executive Chairm an at Advanced Oncotherapy (AVO) tells Jack Ball

p14 003 E ditor’s Letter Welcome to Global Opportunity Private Patients 2016

00 9 F oreword: The UK - first choice for overseas private patients Lord Prior of Brampton

034 R oyal Brompton & Harefield Specialist Care: A global flagship for innovative heart and lung care Responsible for several major clinical breakthroughs, The Royal Brompton and Harefield NHS Foundation Trust remains one step ahead of the game in specialist heart and lung care, says David Shrimpton, Managing Director, RB&HH Specialist Care

037 R oyal Brompton & Harefield Specialist Care: RB&HH Specialist Care in Harley Street

010 Pinsent

Masons: Why attract private patients to the NHS? What are the benefits to the UK of accessing private patients, both from the UK and abroad, asks Kate Orviss, Partner and Head of Global Healthcare Projects Team at Pinsent Masons

014 Harley Street Medical Area

038 S choen Clinic: Back to back Schoen Clinic’s orthopaedic hospital in Harley Street Medical Area, specialising on total spine care, will be a London first with expert multidisciplinary and comprehensive care delivered by world-leading consultants in one single site, says Andreas Ludowig, Managing Director

042 M oorfields Private: Perfect vision

The Harley Street Medical Area continues to be regarded globally as a centre of world class medical excellence, providing cutting-edge facilities within beautiful period buildings

Moorfields Private is the world’s leading destination for expert eye treatment and sets standards for the rest of the world to follow, says Maria Dimmock, Managing Director

044 A nglo Medical: Medical Angel 020 Harley Street Medical Area Home to over 2,000 practitioners, small clinics, full scale hospitals and support services

Karine Solloway from Anglo Medical is helping the world access the best of British private healthcare

048 H CA International: Excellence in private care 022 T he Fortius Clinic: World-class orthopaedic care In the space of five years, The Fortius Clinic in London’s Marylebone is already hitting the big leagues and building an international reputation, says Fortius Group Chief Executive, Jim McAvoy

Home to one of the world’s of the most vibrant healthcare markets, London has some of the most advanced private hospitals covering all manner of specialist care, says Khadija Mouhajer, Director of International Business and Relations at HCA International

in association with

4

Global Opportunity Healthcare Private Patients 2016

| Issue 01

globalopportunityhealthcare.com

Integrated Global Healthcare Solutions The business of healthcare is global. With Pinsent Masons’ network of offices across the world let us help you access and deliver new opportunities wherever they may arise. Our team encompasses experts in all areas from the structuring, development and operation of major and minor healthcare facilities to all forms of partnering and joint ventures to life sciences, intellectual property, data privacy, protection and commercialisation, digital and e-health, research and genomics and medical equipment and IT. Whatever your interest in the business of healthcare, Pinsent Masons can support you every step of the way.

Kate Orviss Global Head of Healthcare Projects T: +44 (0)113 294 5255 E: kate.orviss@PinsentMasons.com

Diane Mullenex Global Head of Telecoms T: +44 (0)20 7490 9250 E: diane.mullenex@pinsentmasons.com

Alison Hubbard Dubai Healthcare Lead Partner T: + 971 4 373 9693 E: alison.hubbard@pinsentmasons.com

Clare Tunstall Global Head of Life Sciences T: +44 (0)20 7490 6357 E: clare.tunstall@pinsentmasons.com

www.pinsentmasons.com I www.Out-Law.com Š Pinsent Masons LLP 2016

052 A new future for the treatment of Multiple Sclerosis?

Pioneering research into haematology is informing new approaches to the treatment of MS. Co-located in one of the UK’s leading NHS teaching hospitals, Harley Street at University College Hospital continues to work with pioneering consultants to advance treatments, as Professor Anthony Goldstone CBE tells Jack Ball

|

Contents

Global Opportunity Private Patients 2016

056 T he Christie Clinic: A cancer treatment powerhouse Dedicated solely to the treatment of cancer, The Christie Clinic is the world’s best unknown hospital, says Professor Sarah O’Dwyer, Clinical Director of the Christie Clinic

064 H ealix Health Services: Accessing UK private healthcare solutions Healix Health Services’ bespoke medical case management solutions are helping overseas insurers and employers access, manage and oversee their medical claims and overall healthcare provision in the UK at preferential rates, says Richard Saunders, Sales Director at Healix Health Services

|

Contents

088 E dgbaston Medical Quarter: Discover a community of medical excellence Edgbaston Medical Quarter in Birmingham is emulating Harley Street with its combined medical and healthcare facilities, says Mark Lee, Chief Executive Calthorpe Estates

093 A n introduction to Imperial Private Healthcare: Academic health With more than 9,000 patients treated every year, Imperial Private Healthcare, part of Imperial College Healthcare NHS Trust, is one of the largest private healthcare facilities in London

094 T he Lindo Wing: Tradition of excellence The Lindo Wing at St Mary’s Hospital in London provides high quality care for complex cases, as well as unrivalled maternity services, says Sarah Cartledge

096 I mperial Private Healthcare: Major trauma Military injuries are complex and challenging, but they offer the opportunity to innovate, Mr Shehan Hettiaratchy, a Lead Surgeon at Imperial Private Healthcare tells Sarah Cartledge

098 H ammersmith Hospital: Determined to raise the bar 068 G reat Ormond Street Hospital: Leading the way in international paediatric care A unique combination of cutting edge experimental research and multidisciplinary care from teams of paediatric specialists cements Great Ormond Street Hospital as an international beacon for world leading paediatric care, says Trevor Clarke, Director of the International and Private Patients Service at GOSH

072 G uy’s and St Thomas’ Private Healthcare: Clinical excellence and world-class patient care Guy’s and St Thomas’ Private Healthcare offers a unique combination of world-class clinical services delivered by internationally recognised clinicians. Both UK and overseas private patients benefit from the highest standards of care from one of the largest and safest NHS Ttrusts in the UK, says Dr Ian Abbs, Chief Medical Officer for Guy’s and St Thomas’ NHS Foundation Trust

078 G uy’s and St Thomas’ Private Healthcare: Building a fresh start The Centre for Pre-implantation and Genetic Diagnosis (PGD) at Guy’s Hospital has long established itself as a world leader in fertility treatment and genetic diagnoses and is the biggest programme in Europe as Mr Yacoub Khalaf, Director of the PGD programme at Guy’s and St Thomas’ NHS Foundation Trust, tells Jack Ball

With its history of clinical innovation and research spanning over 80 years, the Haematology Department at Imperial College Healthcare NHS Trust’s Hammersmith Hospital is unique in its innovative approach to specialist expert care, says Dr Jiri Pavlu, Consultant Haematologist at Hammersmith Hospital and Honorary Clinical Senior Lecturer at Imperial College London

102 A dvanced gynaecological surgery Consultant gynaecological oncologist at Queen Charlotte’s and Chelsea Hospital London, Professor Christina Fotopoulou talks about combining surgical expertise with pioneering research into highly specialised cancer treatment

104 C haring Cross Hospital: A world-class team for complex problems Luxury bespoke care from world-class consultants in one of the UK’s top teaching hospitals makes Imperial College Healthcare NHS Trust’s private facility ‘The Thames View’ at Charing Cross Hospital truly unique, as Matt Williams, Consultant Clinical Oncologist, tells Jack Ball

108 C haring Cross Hospital: Leading the charge Kevin O’Neill, Head of Neurosurgery at Imperial College Healthcare NHS Trust, talks exclusively to Jack Ball about the Trust’s pioneering research into developing and integrating the very latest in advanced surgical technologies

080 G uy’s and St Thomas’ Private Healthcare: A beating heart of clinical excellence The cardiology unit at St Thomas’ Hospital has built a truly international reputation, increasing access for patients from across the globe who may have traditionally been denied access to more conventional heart procedures, as Professor Simon Redwood, Consultant Cardiologist based at St Thomas’ Hospital, tells Jack Ball

084 B upa Cromwell: The full package Bupa Cromwell Hospital reflects its London location with an international flavour and exceptional care, Ahmed El Barkouki, Commercial Director tells Jack Ball

6

Global Opportunity Healthcare Private Patients 2016

| Issue 01

p78 globalopportunityhealthcare.com

Foreword

|

Lord Prior of Brampton

The UK - first choice for overseas private patients It is my pleasure to welcome you to this special edition of Global Opportunity Healthcare focussing on the UK’s offering to private, fee-paying patients from overseas.

The UK has long enjoyed a reputation as a beacon of healthcare excellence, helped in no small part by this Government’s commitment to the NHS and its status as one of the world’s most well-respected healthcare systems.

In terms of private care provision, healthcare brands like the Harley Street Medical Area, as well as various private patient units in some of the NHS’s more internationally renowned Trusts, have long represented the very best in high-level specialist private care. Yet, despite this impressive NHS and private healthcare presence, only 19,000 operations were performed on overseas, fee-paying patients in London in 2014.

With the global private healthcare market averaging two million procedures a year, this disparity represents a huge economic opportunity for Britain. Treating NHS patients is rightly the priority for any NHS provider, and for this Government, but there is a clear advantage from engaging with the the global healthcare market – raising revenues and in turn reinvesting this back into services for NHS patients. The Private Patients edition of Global Opportunity Healthcare highlights how the UK is uniquely positioned to respond to the opportunities represented by this market.

As the world’s largest concentration of specialist healthcare providers, the Harley Street Medical Area is a unique UK asset, and an area that its landlord, The Howard de Walden Estate, is keen to promote internationally. Tenants represented in this edition include Advanced Oncotherapy, whose latest proton beam therapy clinic is set to offer the next generation of precision cancer care; the Fortius Clinic, an orthopaedic and sports injury care centre; and the Schön Klinik: an orthopaedic clinic specialising in spinal work opening in 2017 and bringing with it clinical expertise from its various specialist orthopaedic clinics across Germany.

NHS providers can also offer world leading private treatment. The Royal Brompton and Harefield Trust’s latest specialist heart and lung outpatients and diagnostic clinic on Wimpole Street, and the Pre-implantation and Genetic testing services on offer at Guy’s and St Thomas’ NHS

globalopportunityhealthcare.com

Foundation Trust, alongside their leading cardiology care services - details can be found on pages 72-83.

Spread across five world-famous hospitals, Imperial Private Healthcare’s specialist offerings represent some of the best in UK expertise – from gynaecological and cancer care to major trauma treatments and outstanding maternity services – as we discover on pages 93-110.

Whether a tenant of the Harley Street Medical Area, a private unit from one of the UK’s leading NHS Trusts or an independent private provider, the UK’s private healthcare market offers unrivalled medical expertise.

The NHS is the crown jewel in our public services and together with the private sector we hope to see more fee paying patients making the UK their first choice for healthcare over the coming years.

Lord Prior of Brampton

Whether a tenant of the Harley Street Medical Area, a private unit from one of the UK’s leading NHS Trusts or an independent private provider, the UK’s private healthcare market offers unrivalled capabilities for high-level specialist care.’

Issue 01

| Global Opportunity Healthcare Private Patients 2016

9

Pinsent Masons

|

What are the benefits to the UK of accessing private patients, both from the UK and abroad, asks Kate Orviss, Partner and Head of Global Healthcare Projects Team at Pinsent Masons

Why attract private patients to the UK?

W

hen it comes to private (fee-paying) patients there is a distinction to be made between UK-based private patients and international private patients, and in turn between London and the rest of the UK. London has a number of private patient hospitals, internationally recognised healthcare brands and world-leading NHS Trusts. Many of these Trusts have already set up their own Private Patient Units (PPUs) or have even gone one step further and set up operations outside the UK. With so many private hospitals now located in London, the Competition & Markets Authority is taking a keen interest in this sector. This is a relevant consideration for any organisation considering their options in this market.

Outside London the private patient market is relatively nascent in comparison. But it is one that is growing quickly. A number of private healthcare providers are currently looking to expand their operations by seeking partnerships with worldrenowned NHS Trusts that have proximity to excellent transport links. However, every Trust and private healthcare provider is different and they will all have different issues to consider.

10

Global Opportunity Healthcare Private Patients 2016

| Issue 01

What is a PPU? A Private Patient Unit is a separate facility, ward or series of rooms or beds that are allocated by an NHS Trust purely to accommodate private (feepaying) patients, much as any fully private hospital would do. Given that the NHS must not subsidise private care with public money, this separation is extremely important. The financial benefit to any NHS Trust with a PPU is that income is generated which is then used to enable that Trust to better carry on its principal purpose, ie provision of healthcare for all, free at the point of delivery, based on clinical need not ability to pay. These overarching principles are not adversely affected by an NHS Trust operating a PPU. Any NHS Foundation Trust is permitted to carry out activities “for the purpose of making additional income available in order better to carry on its

globalopportunityhealthcare.com

|

Pinsent Masons

IMAGE: WWW.SHUTTERSTOCK.COM

principal purpose” (s43 of the NHS Act 2006 (as amended)). There are some restrictions around the specifics of this (and NHS Trusts are subject to slightly different approval requirements), but it is on this basis that most NHS Foundation Trusts choose to base their right to set up and operate a private patient business.

Each individual Trust will have different considerations to take into account when deciding whether a PPU is a desirable, viable or valid use of that Trust’s resources. Trusts cannot simply use their NHS facilities interchangeably for NHS and private patients (whether from the UK or overseas).

They need to create separate facilities (which may be physically separate in a different building, a separate ward or series of rooms) that meet certain criteria to attract private patients, with expected standards of care also significantly higher, providing

globalopportunityhealthcare.com

‘A number of private healthcare providers are currently looking to expand their operations by seeking partnerships with world-renowned NHS Trusts that have proximity to excellent transport links.’

Issue 01

| Global Opportunity Healthcare Private Patients 2016

11

Pinsent Masons

|

all manner of other support facilities that may not have been a consideration when providing solely for their NHS patients.

When any Trust is considering whether setting up a separate stand-alone PPU is suitable, it must first establish what its individual goals are. These will not be the same for every Trust, and there are many different legal models that could be used.

For some, a land-based transaction will be best, whereas others may want to consider a joint venture or partnership model. It is about being clear what that Trust is prepared to commit to from the outset.

We can help parties consider all their options and we are used to working with clients to test and challenge their thinking to ensure that they end up with the right solution before they commence any procurement. Changing one’s mind after this point can, after all, be a costly decision.

How can the UK attract more international private patients?

In order for an individual hospital to attract international referrals, it must be positioned to offer clinical excellence alongside international standard facilities and support services.

NHS PPUs in particular can be hugely attractive to overseas fee-paying patients because these facilities give them the opportunity to access the significant reputation of the NHS’s clinical excellence with the luxury and attentive nature of a high level private patient facility.

Bearing in mind the world renowned expertise of certain NHS Trusts, the UK’s internationally recognised healthcare brands and the standard of many private patient facilities it is arguable that the UK should be attracting more international private patients than is the case at present. There may be various reasons for this. It may be that without central organisation, individual companies and Trusts are required to develop their own systems to influence referral opportunities. Other countries may be investing more in those states where we are trying to obtain more referrals. Some of the facilities may not offer the full range of services needed, or perhaps are not yet equipped to deal with the cultural sensitivities that some international patients demand. These are not necessarily legal requirements, but they are important commercial considerations.

In other attempts to increase referrals a number of Trusts are also looking to set up some form of operation overseas. This can range from the establishment and operation of a facility in a new jurisdiction to a joint venture relating to training, or helping with the development of clinical pathways.

Pinsent Masons is working with several Trusts and other healthcare providers in a variety of jurisdictions, using our own local presence to help our clients navigate the nuances of doing business in a new market. Our presence in the Middle East, in both Dubai and Doha, is particularly relevant for the private patient market. Being seen to invest in the local market can enhance the number of referrals to related UK-based operations. Often the most helpful

12

Global Opportunity Healthcare Private Patients 2016

| Issue 01

‘Selecting to have treatment in the UK, being able to access the clinical excellence and standards of care offered generates a significant economic benefit for the UK as a whole.’

globalopportunityhealthcare.com

|

Pinsent Masons

KATE ORVISS Kate leads our Global Healthcare Projects Team which advises both public and private sector participants on major healthcare projects, joint ventures and partnership arrangements around the world. We are independently recognised as market leaders in this area and our team has experience in the UK, Turkey, the Middle East, Africa, China and Australia. Kate also interfaces closely with our wider healthcare team which includes experts in health sector related corporate finance and M&A, investment and real estate, life sciences and pharmacy, digital and e-healthcare, data privacy, protection and commercialisation, research, regulation and intellectual property advice.

IMAGE: WWW.SHUTTERSTOCK.COM

support you can get when looking at new markets comes from someone who simply knows the way things work and how to protect you against some common pitfalls. We can then build on this network to support you every step of the way to achieve success, whatever your ambitions may be.

Benefits of private patients

The term Medical Tourism (being the referral of a patient from outside the UK for treatment which is paid for by the overseas individual or foreign government) generates the misconception that such an overseas private patient can access treatment to the detriment of a British national seeking treatment under the NHS. However this is not the case for the reasons outlined above. A separate issue surrounds

globalopportunityhealthcare.com

protecting the NHS from those who seek to access treatment, generally abusing the fundamental principles of provision of healthcare for all, free at the point of delivery based on clinical need, not ability to pay. These issues are beyond the scope of this article.

Medical Tourists are highly sought after by private hospitals and NHS Trusts operating PPUs. Selecting to have treatment in the UK, being able to access the clinical excellence and standards of care offered generates a significant economic benefit for the UK as a whole. Medical Tourism that selects an NHS PPU generates income, experience and opportunities for the wider benefit of the NHS. NHS funding has been relatively well protected

by Government, but with costs still rising some Trusts can generate additional revenue that can be reinvested to provide more, or better, NHS service by exploring their opportunities with private patients and opportunities overseas.

Trusts or private hospital providers seeking to attract further private patients (either from the UK or internationally) are likely to have to consider how they can create additional capacity. Pinsent Masons can help clients understand their options and identify their strategy, and then help implement the best course of action. There is no ‘one size fits all’ solution, but increasingly these options will involve joint partnerships between the public and private sector. These relationships can help NHS Trusts access new markets, technology, training opportunities and co-located services. With our experience of advising both public and private sector on all forms of structures in the healthcare sector and other markets, Pinsent Masons is perfectly placed to help all participants work out the best solution for their interests in the private patient environment.

Further information Email: Kate.Orviss@pinsentmasons.com

Issue 01

| Global Opportunity Healthcare Private Patients 2016

13

Harley Street Medical Area

|

The Harley Street Medical Area 14

Global Opportunity Healthcare Private Patients 2016

| Issue 01

globalopportunityhealthcare.com

|

Harley Street Medical Area

Royal Brompton & Harefield Hospitals Specialist Care

The Harley Street Medical Area continues to be regarded globally as a centre of world class medical excellence, providing cutting-edge facilities within beautiful period buildings

I

t used to be that the defining characteristic of the Harley Street Medical Area was the richness of its history: a heritage that stretches back to the 19th century, when medical practitioners first began to congregate in this attractive corner of Marylebone, central London. That sense of heritage remains, embodied by a beautiful Georgian streetscape, but in recent times the past has become less relevant to an area that, instead of looking backwards, has evolved into a thoroughly modern enclave with a global outlook and genuine sense of momentum.

This has not happened by accident. In recent decades, the area’s landlord, the Howard de Walden Estate, has made a concerted effort to attract world class medical tenants. It has done this by identifying any gaps in the area’s offering, and approaching those who are most respected in their medical fields, with an emphasis on complex care rather than low cost treatments.

To draw the highest calibre of clinicians, the Estate has needed to offer the highest standard of medical accommodation. This is no easy task in a conservation area, but advances in medical technology, an acute understanding of planning requirements and the acquired experience from its many years as the area’s steward have allowed the Estate, working in tandem with its tenants, to provide cutting edge facilities within beautiful period buildings.

globalopportunityhealthcare.com

Issue 01

| Global Opportunity Healthcare Private Patients 2016

15

Harley Street Medical Area

| 16

Global Opportunity Healthcare Private Patients 2016

| Issue 01

globalopportunityhealthcare.com

|

As a result of this strategy, the area’s long established and justifiably famous tenants—The London Clinic (including The London Clinic’s Cancer Centre, which houses some of the world’s most advanced radiology equipment), HCA, King Edward VII’s Hospital—have in recent years been joined by some exceptional new peers: Royal Brompton & Harefield Hospitals’ brand new diagnostics and outpatients centre; the flagship hospital of eye specialists Optegra; Isokinetic’s Fifaaccredited rehabilitation centre; the multi-specialist London Claremont Clinic. And there are more to come: Advanced Oncotherapy’s proton beam cancer therapy unit is on its way, as is a London base for Germany’s highly regarded Schoen Clinic.

Tangible benefits For both patients and clinicians, the benefits of more than 2,000 medical services concentrated in such a small area are tangible. As well as hospitals and clinics, the Medical Area is home to hundreds of small practices and independent clinicians, between them covering just about every conceivable medical specialism, as well as dentistry, psychiatry and a whole host of other related sectors. If a patient needs referring to a different specialist, or if particular type of specialist technology is required, this can be found in the immediate vicinity.

globalopportunityhealthcare.com

Clockwise from top left: Cancer Care at The London Clinic; Royal Brompton & Harefield Hospitals Specialist Care; Isokinetic; The Harley Street Clinic, part of HCA Healthcare UK

Harley Street Medical Area

Inevitably, given the size of the medical community, other related services have been drawn to the area too, extending these local networks still further. Physiotherapists, nutritionists, fitness trainers and pharmacists, for example, are all close at hand when their expertise is required. Many significant institutions, including the Royal Society of Medicine, British Dental Association, Royal College of Nursing and Academy of Medical Sciences, are also based in Marylebone, making this a real hub of research and professional support.

In addition, bigger NHS brands such as Moorfields Eye Hospital NHS Trust and University College Hospital NHS Trust are already opening private facilities in the Medical Area. “By bringing in private patients from overseas, particularly the more complex cases, the fees charged provide additional cash that can be reinvested in the NHS. Generally, private healthcare in the economy brings in revenue and taxes and helps to retain the best doctors, helping to provide a better healthcare system,” says Simon Baynham, Property Director at the Howard de Walden Estate.

Perhaps the most unusual aspect of the Medical Area—and one with a clear appeal for patients and their families—is that it isn’t an isolated enclave, filled with nothing but doctors. Surrounding the medical buildings, and sharing the same streets with them, are restaurants and cafes, shops and cultural

Issue 01

| Global Opportunity Healthcare Private Patients 2016

17

Harley Street Medical Area

|

Harley Street Medical Area

|

‘If a patient needs referring to a different specialist, or if particular type of specialist technology is required, this can often be found in the immediate vicinity.’

institutions. There are numerous hotels, many of which have developed close ties with the hospitals and clinics and have developed special medical packages. There are quiet parks and attractive streets. For patients undergoing treatment, or for the family and friends supporting them, the Harley Street Medical Area provides an environment that is both comfortable and laden with welcome distractions.

Its Marylebone location provides an unrivalled level of accessibility. Sitting right in the heart of a truly global city, the Medical Area is connected not just with the rest of the UK but with the entire world.

It is a short journey from several airports including Gatwick and Heathrow, two of the busiest and best served in Europe. It is closely tied in to London’s

18

Global Opportunity Healthcare Private Patients 2016

| Issue 01

vast public transport network and is just a short hop from numerous mainline stations including the Eurostar terminals at London St Pancras International station. With Crossrail due to open on the doorstep in 2018, this is an area unrivalled in its transport connections and convenient travel modes.

In recent years, the Howard de Walden Estate has been working to bring clinicians together to help improve the patient journey and offer a more cohesive service. Many of the area’s institutions have been building strong links with other countries to help them better understand the requirements of international patients, and a number of them are collaborating to provide medical concierge services.

The Estate is building a Harley Street Medical Area website to provide comprehensive listings of the medical excellence in the area.

This collective approach, led by the Estate, has allowed the area to improve its profile with patients, practitioners and visitors from around the world which, unlike others in the global medical marketplace, receives no state funding. When it comes to opening doors its famous history certainly helps, but it is the clinical excellence of the Harley Street Medical Area that firmly routes this place as a world-class destination.

Further information www.harleystreetmedicalarea.com www.hdwe.co.uk

globalopportunityhealthcare.com

35

1-8

33

1

10

11

2

11

15

8

7-8

17-19

9 9

4 1

13

REGENT’S PARK

1

EAST ARE SQU PARK

20

35

23

20

1 9-14 13 3 1-13 13

115

153 86-91

1 131-15

171

159

3 63-7

93-95

157c 7 155-15

121 119

9 143-14

113 111 109

49

104-108 109110

125-129

101 23-25

117-123

111-113

91

83-89

107-109

26 30 32 33

4

29 28

6 23

99

34

17

37

35

37

0 18-2

81

7

6

24

47

22

-21 17

13 7 14

9 7-12 12

66 67 68 70 71 72

73

187-193

179-185

177

77

12 11

7 15 513

64 65

201

199 197 195

15

1 17 116

1 59-6

63 62

205

5 14-5

4 35

40

41 42

15

13

15

6

65

7

95

11

5

87-93

9b

3

85

9a

79-83

49

43-47

77 3

37

75

61 51

125

207

105 23

47

11

12

32

67 27

71 73

1a

67

5

7-10

5 63-6

10a

14 15

19

47 39 37

9 313-31 1 307-31

29-33 27

295

3 289-29

21

261-271

20

17-28

249

247

245

1 235-24

229

227 223

18

0 10

4 6a

6

9

18

12

12 a

10

18 20

28

22

373

379-383 385-389

391 393

395 397

399-403 23-38

13

10

7

401 407-409

30 -28

413 415 417

19

65

11-12

6 10

0 11

26

371

21 5 10

6

24

369

19

241

243 253-259

2 6

1 5 7

7 8

94

95

18

10

25

12

7

1 3 5

19a

1b

23

11

7

19

24

20

74-77 1c

53

1 2

3

27

25

17 19

79

80

87

59

35

71

72

18

18 20 19

86

19

17

7 54-5

12

10 59

7 53-5

51 49

10

22

89

11

3

18

16a

64

63

55a

55

56

57-59

60

61 62

68-73

1

5 17 3 17

24 24 68

53

24 4

7

15 10

3-6

9 69

30

19

21 23

34

105

103

101

93

17

51

57 57a

45

48

54

35

29

21-27

7

1 77-8

75

73

71

5a 5b

1

115 2

1a

23 1 19-2

46

1 3 40

39a

61

37

7

19

117a

117

3 2

115a

12

20

44

21

13

36 37

1

3

69

63-65

57 47 43 39

15 13-14

12

59

4 5 7 6 8 9 11 10

26

7 55-5

22 24 1-12 13-56

5

57-68

102-103

105 104 107108

229

8 4

14

54 92

93

94

95

96

12

31 27 26

131

4

35

41

0 38-4

23

9 47-4

74-75

76 78 77 79 81a 81 83a 82 83-84 85-86 87 89 88 90 91

10 11

215-227

1 34

149

147

143

135

11 10 9 6

123 125

64 66 65 67

28

68 69 70

1

71

72-75

13

11 7 5 3 1

2-32

1-6

17

1-14

17

22

28

63

9

25

21

4a

5

43 35

19 20

4

4b

1

37

12

7

8-12

1

2-3

9

7 3

0a 11

5

15

5-11

109 110 110a

5

363-367

20

14

22

16

23

26

45

355-361 23

3 18

13

20

28

14

64

19-24

64

63

24

112 111 116-117 115 112-114

38 39

353

8 4

3

6 8-12

18

56 9

62

3-5

4

66

73

419

421-429 431-433 443 445

1-36

61

25

98-101

9

351

11 78

1

5

67

58

6

57

1

1

29

1a

11-12

6-7

68

56

13

5

9

93

11

1

341-349

-18 16

-16 12

13-14

8

56 a

8

15

14-15

321-239 23

4

75

1-2

3

5

6

9

4

7 34-3

16

315-319

13

18

27

28

313

339

19

29

6

91 90

311

33

6

301-309

17-20

299

20 7

19

47

12

297

HANOVER SQUARE

20

2

13

295

13-14

293

11-12

291b

2

291a

23

289291

19

3

44 224-2

3

7-10

-23 20

4

75

22

250

24

10

76

51

17

254

24-25

7

7

283

252-260

-26 25

80

50

25-47

21

260

14

ET RE ST ND BO

30

262264

2

-30 29

12

17

9

1

6

26

1 6 11-12 13

W NE

8

2

42

27

T TREE IES S DAV

Bond Street (Crossrail 2018)

ET T STRE REGEN

3

2

26-28

266268

7

4

5

REET RD ST OXFO

308-318

27

11-13

17

1

246

266

278-306

227

38

43

2

214-234 240

242 244

Oxford Circus

271 273

17 16 18a 18b

13

3

270 268

250

252-258

260

21

11

6

4

1-10

7

24-25

5-7

37

14

12

35

288

8 36-3

22-27

11

ET RE ST RE VE

8

50

290

11

21

22

7 26-2

23

10

1-24

6 54-7

292

273-287

14

28

7 10

11

13 12

14

15

257-261

31

9

47-48

296

1

40

37

1 1a

Royal College of Nursing

324

32-36

300

T TREE NT S REGE

2 39 34-36

33

8

6-12

2

38

24 23

30 29

33

REET ET ST GAR MAR

22a

-40 28

2-6

16-18

1-16

4

30-48

5

50

6

52-56

8

60

302-308

5

2a

68

310-312

7

2

76

9

17

University of Westminster

CAVENDISH SQUARE GARDENS

REET ES ST HOLL

10

78

10

15

14

31

The Royal Society of Medicine

11 12

314a

8

2

12

82

314-322

1 3 7-11

9 15-1

8

11

324

4

0 15-2

84

326

8

14

5

86

51

6a

90

52

1a

92

53

1

94

2

2

96

1-2

1

T TREE LEY S HAR

56

6

98

1a

13

10

21

CE H PLA NDIS CAVE

16

5 103-10

35

65 67

2

37-72

449

451

499 20

24

8 7

100

47

11

102

1

20

91 97

99

12

2

3

40

15a

112

12

104

EET S STR NDO CHA

22

72 70

74

76 78 80

82

90

2

4

14

9

11 14

3

ET STRE ECK WELB

42

16

116

13

112

9

30

6

9

ET STRE POLE WIM

7

44

17

118

17

118

8

2

40

11-12

8 10 9

11

18

120

134

14

42

16

16

11a

50

1a,b,c

24

122

136

16-20

44

17

17

12

1

138

T TREE ND S RTLA T PO GREA

55

2

140-142

49-53

148150

26 28

43-47

3-8

152-156

36

24

16

4

ET STRE POLE WIM

REET D ST SFIEL MAN

5

6

25

ET STRE ECK WELB

3

19

160-172

67

174-182

63-65

184-188

44

61

92

190

50

T TREE AM S HALL

32

7

52

27

10

19-35

94

8 20-2

EET R STR OLVE BOLS

196198

T TREE LD S CHFIE T TIT GREA

202

0 56-6

1

34

17

58

T TREE LEY S HAR

10

29

12

14

16

1b

15

17-21

1

55-59

1

1-38

1-36

REET E ST DUK

20

21

129

96

204a

T TREE ND S RTLA T PO GREA

6 204-20

10

98

208

14

0 10

210

2

46

23

22

60

11

29a

14

13

334-348

36

4-7

212

83

1-3

214

69

8 10

184

216

9

12

3-10

186

218

52

11

2

2 12

188

220

60a

60

E PLAC LAND PORT

1

62

2

30a

17

14

1-3

7

3-9 15

350-352

34 35

2527

23

21

17 19

15

2 5-11

10

23

2-5

22

1

6 12

222

66

14

30

18

2

14 12

18

12

48-60

45

8 224-22

8

70

9

T TREE LEY S HAR

ET STRE POLE WIM

10 20

25

23

1-5

4 13

REET R ST OLVE BOLS

230

4 84-9

78

10

88

40

Isokinetic

CE TA PLA RIET HEN

368370

48

36

Chandos House

4

29 27 33 31 37 35

6-8

2

35

35c

35 29

27

25

46

30-34

9

26

28-30

32-34

24

7

Marble Arch

76

38-40

26

12

90

41

12

354-358

1-22

19

13

23

Wigmore Hall 36-40

E AN EL ON LEB RY MA

9

29

REET E ST DUK

8

480-504

508-520

T TREE AM S HALL

82

29

17 18

100

43

60

25

21

372374

128

120 116

2 108-11

1

274 272

1

24-25

23

STREET OXFORD

E PLAC LAND PORT

45

112a

112

T TREE LEY S HAR

43a

20 19

6

360-366

400

1-12

2

0 114-12

95

1

21

62

13 12

21 7

93-97

91

14

31

64 14

23

19

1-2 3-4

Selfridges

464-458

86

128

111

26

66

67

69

79

1

85-89

The Howard de Walden Estate Head Office UME Diagnostics/ London Musculoskeletal Centre Nuada The King’s Medical Society Fund of London

56-60

1-11

10

11 13-25

3 4

2

10

ET STRE NNE EN A QUE

328 332 330

REET D ST HAR ORC

12

3-7 1

0 106-11

130

47

5

2

1

22

10

8

24a

8

37

2 3

39-49

17

1

105

42

35-38

62

74

78

88

5

Optegra

39

15

2

103

46 43-45

90

92

78

18

44

42-46

66 64

10

6 5

67 69

48

54

51-61

95-97

101

ET STRE ORE WIGM

40

94

1

3

5 4

27a

40

50-54

56

4 40-4

79

82

23

Schoen Clinic REET London Ltd WIGMORE ST 58

157b 157a

1

9

73

24

70

120-118

122

130 132

4 144-13

10

1-12

10 8

The Association ET STRE of Anaesthetists of Midwives HESS DUC Harley Street T Dental Studio E E STR HESS BBC DUC

Queen Anne Street Medical Centre

21

22

23

68

37

7-3

110 112

24

72

2

13

108

4 116-11

5 33-3

17

104

ET STRE ORE WIGM

19

13

1-15

23

21

6

96 20

14-15

58a

9 -1 17

21

22

23

24

3

REET H ST NDIS CAVE NEW

REET H ST NDIS CAVE Royal College NEW

74

58

1-8

00 96-1

62

56

58

76

7

EET R STR BAKE

PORTMAN SQUARE

18 15

23

3

82

19

7

30b

8 4

92

61

1

11

34

29

31

32

7

71

76

London Claremont Clinic

2

9 7

35

53

51

ET STRE NNE EN A QUE 60

62

9

10

11

38

33

The Doctor’s Nuada Laboratory Medical Group The Royal Brompton T The London EE R CK ST N TI Orthpaedic BEN Clinic IVI Fortius (UK) Ltd Clinic 4

88

8-14

2

14 15

43

14

LANE ONE YLEB MAR

PLACE EVILLE MAND

8

11

1a

Academy of Medical Sciences 37

42

41

40

Royal National Orthopaedic Hospital

2

11

19

17

53

94

19

4 13-1

12

48

11

98 100 96

24-27

STREET THAYER

29 28

18

1

6

8

20

20

1a

9

12

43

3

102

30

1 4 7

Fortius Clinic

12 15

40

1

108

E LAN

32 31 34 33 36 35

26

2-14

18

14

32

33

The London Eye Hospital

The Marylebone Hotel

8-10

1

2

8

9

5

10

12-14

33

2

37

ET E STRE HIND

MANCHESTER SQUARE

2

15

1

5

22-25 21

9

17

23

REET TH ST MOU WEY 32a

British Dental Association

7

14

13

12

25

2

16 14

22

16

24

1

73

23

16

15

75

15

7

8

9

11 10

ET STRE ECK WELB

2

22

3

11

3

13-16

1

The Wallace Collection

7

77

22

65

56 48-52

46

44

0 38-4

36

4 32-3

Alliance Medical

114

118

20

90a

60

35a

4-5a

17

34

16-18

6

21

5

12

T TREE ND S RELA TMO WES

7

6

0 16-2

71

21

27

11

5

8

1

3

28

TH MOU WEY

39

38 37

6-10

T STREE

11a

The Harley Street Clinic

45

43

42

22

1a 120-12 2

22

1

20

33

33

67

8

9

7 5

9

26

58

Royal Institute of British Architects

59

35

33

31

7

4

25

39a

41

37 39

10

79

37b

T STREE DISH CAVEN 29

27

25

21

19

17

NEW 22 24

18

6 14-1

12 6 10

MAR YLEB ONE

4 2 2a

11-13

88-110

69

15

11

28

24 26

22

20 14-18

10 12

10

1

4

3

6 24-2

39

35

6 8

11

3

ET E STRE GEORG

25

37

14

14 13 17 16 15

5

17

1

19

4

6

32

56

9-15

8 6

4 2

EET E STR NSHIR DEVO

12

55

25-31

7

5

3

4

42

T STREE RGE GEO

3

16

20

7

13

22

6-12

5 7

3

UCLH

22-28

14-20

9

15

34

36

58-60

NE STREET MARYLEBO

21

6-8

50

62

23 22

21 19

12 10

6

44

64

24

25 23

14

47-53

5

34

71

25

10 28

24

EET R STR BAKE

73

26

EET STR

61

63 65

65 63

1

108 Medical Chambers

35-37

43

49

58 57a

2 4

47

46

39 48

39

51 53-55

27

11-16 30

19

1

29

17 40

29 27

2

30

EET AYBROOK STR

22

STER CHE MAN

35

37-43

8 7

31

1

27

1

11 12 13

BLANDFORD STRE ET

55

12

32

4-5

3

1-30

4 9

12

59 57

HIGH STREET MARYLEBONE

6

5

2 72-8

1

3

7

5

42-46 50

3 6

11a

12

EET E STR NSHIR DEVO

The London Oncology Centre

REET TH ST MOU WEY

54

61

67-69

The Harley Street Clinic Consulting Rooms

40

Moorfields

34

The Weymouth Hospital

56-60

64 62

66

REET LE ST IMPO ER W UPP

12

33-34

7

6

84

EET MOXON STR

26-28

44

3-5

14

35a 35d 35c

8

7

86

2

15

36

3

8

88

2-6

8-10

3

King Edward VII Hospital for Officers 40

8 10

16

17

38 37

1

66

9

92

PADDINGTON STREET GARDENS 1

37

Devonshire Hospital

39

64 65-66 61 62 63

33-51

55-83

6

40-41

1-9

57 58a

56

59-60

1-8

1a

34

33

32

21b

21a

35

30

28b 28a

28c

38

EET E STR NSHIR DEVO

22

2

8

6 74-7

8 35-3

11

42

14

25

78

1 41

27

27a

27b

28

26 25

1 2 88

31

12

London Medical

3

4

5

6

7-9

10

53 54 55

51-52

49 50

13

43-47

16

24

40

49

2

23

18

17

EET T STR MON BEAU

5

Medical Research Council

114a

21

50

32

6

STREET

29

39

35

51

30 31

29

18

82

6

24 28

The London Clinic Consulting Rooms

20

26

2

84

11

N STREET PADDINGTO

32

33

29

27

16-18

20a 19

1-20

34

27

23

26

52-54

30

5 7

NOTTINGHAM

22 23

55

1-20

24

The Portland Hospital

16

92

30

Advanced Oncotherapy

114

2-5

28

27

55-57 28

20 21 22

9

PLACE NOTTINGHAM

16

1

GH STREET LUXBOROU

Princess Grace Hospital

18-25

CRES C EN T 98

27

17

57

Viavi

25

24

LACE IRE P NSH DEVO

27

29

PAR K

140

The London Clinic

The London Clinic Cancer Centre

19

25

58

D ROA ONE YLEB MAR

15

17

232

20

Baker Street

The Harley Street Clinic Imaging Centre

T TREE LEY S HAR

49

209

PARK CRESCENT

26

Royal Academy of Music

54

48

56-68

69-87

234

6 34-4 47

50

51

3 38

5 38 7 38

240

22

1-1 2

1-5

3 26-3

21

42-55

101

5 18-2

T WES ACE TERR YORK

20

Regent’s Park

15-27

28-41

14-17 19

Great Portland Street

44

43

8 12

9-12

18

D ROA ONE YLEB MAR

14

26

305

6

45 48 99

17

1

41

42

1

1-8

16

1

6

2

GATE YORK

15

355

357

359

361

365

367

371

373

375 379

52-55

32

24

EAST ACE TERR YORK 12

270

13

7

D ROA ONE YLEB MAR

PARK SQUARE WEST

245

12

1

48 50 49

5

3

7

24

CE K PLA SWIC BRUN

23

338

350

2

3

2

1

89

10

5

22 21 20

19 18

10

87

1-17

IRCLE ER C OUT

19

T WES ARE SQU PARK

|

17

Harley Street Medical Area

Home to over 2,000 practitioners, small clinics, full scale hospitals and support services

| Harley Street Medical Area

Harley Street Medical Area

Immunology Infectious and Tropical Diseases Interventional Cardiology IVF Joint Pain Knee Surgery Laparoscopic Surgery Lung Cancer

Key The Howard de Walden Estate Boundary 2016 Harley Street Medical Area Hospitals Partners attending Arab Health 2017 Marylebone Village Retail Destination London Underground

Clinical Pharmacology Connective Tissue Medicine Craniofacial Surgery Critical Care CT Scanning Cytopathology

Crossrail (2018)

Accident and Emergency Medicine Acupuncture Allergy and Environmental Medicine Anaethesia Andrology Audiology Audiovestibular Medicine Back Orthopaedics Bariatric Surgery Bone Densitometry Bone Tumours Breast Surgery Cancer of Head and Neck Cardiology Cardiac Radiology Cardiac Rehabilitation Cardiac Surgery Cardiothoracic Anaethesia and Surgery Cardiovascular Sciences Cervical Screening Chest Pain Clinics Child Protection Children’s Orthopaedics Child Psychiatry Chiropody Cognitive Behavioural Therapy Colorectal Surgery Conservation Dentistry Clinical Biochemistry Clinical Neurology Clinical Oncology

globalopportunityhealthcare.com

Dental Hygiene Dental Implants Dental Laboratories Dental Radiology Dental Surgery Dermatology Diabetes Digital Breast Imaging Endocrinology ENT Surgery Fetal Medicine Fluoroscopy Gastric Surgery Gastroenterology and Endoscopy General Dentistry General Practice Genetic Oncology Genitourinary and HIV Medicine Geriatrics Groin and Hernia Surgery Gynaecology Haematology Hair Transplantation Hand and Orthopaedic Surgery Hand Surgery Head and Neck Surgery Hepatobiliary Hepatopancreatobiliary Surgery High Altitude Specialists Histopathology Hypertension Hypnotherapy

Mandibular Surgery Maternal Medicine Maxillofacial Anaesthesia Medical Concierge Microbiology MRI Scanning Musculoskeletal Injury Practice Musculoskeletal Medicine Neonatology Neonatal and Paediatric Surgery Nephrology Neuroanaesthesia Neurodisability Neurology Neurophysiology Neurosciences Neurosurgery Nuclear Medicine (including PET Scanning) Nutritional Medicine Obesity Specialists Obstetrics Oncology Ophthalmic Surgery Ophthalmology Oral and Maxillofacial Oral Surgery Orthodontics Orthopaedic Surgery Osteopathy Otology Otolaryngology Paediatrics Paediatric and Adolescent Endocrinology Paediatric Cardiology Paediatric Intensive Care Pain Management Pancreatic and Endocrine Surgery Parasitology Parathyroid Surgery Pathology Pathology Services Performance and Exercise Medicine

Issue 01

Perinatal Psychiatry Periodontics Phlebotomy Physiotherapy Plain Film X-Ray Podiatry Prosthodontics Psychiatry Psychology Psychotherapy Radiology Reconstructive Surgery Renal Transplantation Reproductive Medicine Respirology Respiratory Medicine Restorative Dentistry Rheumatology Sclerotherapy Surgery Sexual Health Sleep Medicine Speech and Language Therapy Spinal Surgery Sports Medicine Practice Stop Smoking and Addiction Services Stroke Medicine Travel Medicine Transplant Surgery Trauma Surgery Ultrasound Urodynamics Urological Surgery Vascular Medicine Vascular Studies Vascular Surgery Weight Loss Clinics Women’s Health

Further information www.harleystreetmedicalarea.com www.hdwe.co.uk

| Global Opportunity Healthcare Private Patients 2016

21

Fortius Clinic

|

World-class orthopaedic care In the space of five years, The Fortius Clinic in London’s Marylebone is already hitting the big leagues and building an international reputation, says Fortius Group Chief Executive, Jim McAvoy

H

aving opened its doors in 2011, The Fortius Clinic London has firmly established itself as a leader in private orthopaedic and sports injury care and treats world-class athletes and sports stars as just some of its high profile clients.

The clinic has now grown to become the biggest single orthopaedic and sports exercise medicine group in the UK, a significant achievement considering London’s vibrant and often crowded private healthcare market.

With healthcare giants like HCA International and BMI healthcare continuing to represent stiff

22

Global Opportunity Healthcare Private Patients 2016

| Issue 01

competition, the Group remains firmly committed to balancing clinical excellence with patient affordability.

“It’s not just about how cheaply you can do something”, says Jim McAvoy, Chief Executive at the Fortius Group. “It’s about whether you can actually deliver. It’s about excellence, throughout the treatment pathway, not just business success.

It is this corporate philosophy that has driven the Clinic’s growth. Since its inception the clinic has grown from housing a modest group of 12 to nearly 60 consultants, who are all now operating under the Fortius banner.

globalopportunityhealthcare.com

| The Fortius experience The Group’s flagship clinic is situated in a quiet residential street in London’s Marylebone, and within ten minutes walking distance from London’s famed Oxford Circus. Here, Fortius Clinic offers a unique integrated model of care from experts across a range of surgical and non-surgical specialities, working together to offer a uniquely tailored personalised care approach for all who walk through its doors. Specialists represented at the Clinic include world leading orthopaedic surgeons, podiatrists, musculoskeletal physicians, radiologists, rheumatologists and sports physicians.

“Our service extends across the patient pathway from referral, patient presentation, assessment and diagnostics, to treatment, rehab and recovery,” says Consultant and Knee Surgeon Mr Andy Williams.

“Taking ownership of the patient pathway is a key ingredient of the Fortius service offer.”

The latest surgical equipment is also on hand, offering unrivalled levels of diagnostic, surgical and on-going care. These include in-house radiology facilities from digital X-ray, ultrasound, MRI scanners, and interventional radiology services to state of the art diagnostic and therapeutic procedures.

And with world-class specialists, the Clinic caters for a wide spectrum of patients, from high performance and recreational athletes with sporting injuries to people with musculoskeletal conditions, chronic pain and fatigue syndromes.

It comes as no surprise that the Clinic has even been inaugurated by FIFA as a Medical Centre of Excellence, joining a prestigious list of 37 medical

globalopportunityhealthcare.com

Fortius Clinic

JIM Mc AVOY Jim has been Chief Executive of Fortius since 2010, leading the development and implementation of the company’s strategy and planning.

He began his career as an accountant, and then spent 10 years as a senior executive with a conglomerate, starting in finance and investments before moving on to run an international portfolio of diverse interests including healthcare. He has subsequently built up many years of senior management experience in a range of industries in the UK and abroad, including strategic consulting and performance management.

centres and clinics worldwide accredited to the highest standards of clinical care and excellence.

“We enjoy a special reputation in elite sport and we are proud that our high standards of performance in football are being recognised today,” says Jim, speaking at the FIFA inauguration ceremony. “If you’re looking after athletes and multi-million pound assets, then you’ve got to be pretty good at what you do – we’re extremely proud of our record for delivering high quality care to all of our patients”.

Issue 01

| Global Opportunity Healthcare Private Patients 2016

23

|

Fortius Clinic

Fortius Clinic

Surgical Excellence

|

With consultants holding regular interdisciplinary meetings to discuss the most effective course of treatment for the most complex cases, surgery will always be considered as a final option.

When surgery is required, procedures are currently undertaken in operating theatres within some of London’s internationally renowned private hospitals. They include the BUPA Cromwell Hospital, The London Bridge Hospital, The Lister Hospital, and the Hospital of St John and Elizabeth.

This year the Group opens a new surgical centre in the heart of London, close to their Marylebone clinic and within the Harley Street medical area.

Behind the elegant Victorian façade, the dedicated orthopaedic surgical facility has three fullyequipped theatres, and state of the art medical equipment. This dedicated day surgery centre is designed to provide an optimum operating environment, maximising efficiency and minimising the amount of time patients spend in a surgical setting.

Leading from this preferred surgical route in the United States, day surgery centres have been shown to deliver improved quality and customer service.

Such expansion has been driven by a commitment from all to patient satisfaction, efficient physician practice and the highest level of clinical excellence.

Further information www.fortiusclinic.com

24

Global Opportunity Healthcare Private Patients 2016

| Issue 01

globalopportunityhealthcare.com

108 Medical Chambers

|

IMAGES (THIS PAGE): WWW.SHUTTERSTOCK.COM

Joining the dots Ensuring rapid diagnoses and specialist treatment from some of the world’s leading consultants is the name of the game at 108 Medical Chambers on Harley Street, as Managing Director Hamish Millar, and Chairman of the MAC (Medical Advisory Committee) and leading consultant, Simon Marsh tell Jack Ball

C

ompared to some of the private healthcare ‘giants’ in the Harley Street Medical Area, 108 Medical Chambers operates a relatively small, but close-knit, independent and highly specialised medical practice. Founded in 1991 by Jerry Gilmore, international general surgeon and pioneer of the “Gilmore’s Groin” operation, the Chambers was borne from a desire to bring together some of the UK’s leading consultants under one roof for patients looking for the very best in specialised expert treatment.

“The Chambers was developed to improve overall patient care, and reduce the ‘dotting up’ of services between different specialisms in Harley Street,” says Hamish Millar, Managing Director at 108 Medical Chambers. “With the premise to provide

26

Global Opportunity Healthcare Private Patients 2016

| Issue 01

a ‘one stop shop’ on Harley Street to reduce delays in access to diagnosis and treatment, the services have developed in more recent years as the profession has moved away from the traditional role of general surgeons and towards super specialists.”

In addition to The London Breast Clinic, which is believed to have established the first multidisciplinary team in private practice in 1991, the Chambers has now incorporated five other specialist clinics (see box overleaf). Their onsite X Ray and Imaging and local anaesthetic theatre also allows same day consultation and procedures wherever appropriate, meaning consultants can begin their patient’s treatment pathway much faster than otherwise possible.

globalopportunityhealthcare.com

|

108 Medical Chambers

HAMISH MILLAR Hamish is a qualified accountant, a fellow of the Chartered Association of Certified Accountants. He is currently Managing Director of 108 Medical Chambers a leading independent consulting rooms and diagnostic centre in the heart of London’s Harley Street. He is also non-executive director of The Independent Practitioner business journal. He commenced his training with PKF within their specialist GPs and Dentists department so has had exposure to the medical environment from the mid eighties.

Other roles have also included Finance Director within a group that dealt with out-sourcing of local authority blue-collar services and setting up a cash and carry group.

SIMON MARSH

Familial atmosphere Consultants working in the Chambers run their own individual practices and have admitting rights to their chosen hospitals. But they do not simply send their patient to hospital – they take the patient there themselves. “All care is delivered by the consultant,” says Hamish. “Although nurses may help with dressings or radiographers with imaging, everything that we do at the Chambers is consultant-led.”

This is not to say that interaction between different specialists is minimal. Hamish is committed to fostering a close-knit clinical environment between all consultant specialities, shown to benefit both patient and clinician.

“It’s always about ensuring the patient is happy.

Although each consultant is running their own private practice, everyone is happy for their colleagues to look after their patients if they’re unavailable, should the patient have a problem that needs to be addressed quickly.”

“There is a trust and mutual respect amongst the team – rather than working as individuals under one roof, they choose to work together. And patients over time have come to realise that actually everyone shares this same ethos.”

Having the correct clinicians from the outset who can foster this environment of mutual respect is critically important for all consultants operating in the Chambers. Mr Simon Marsh, consultant surgeon and Chairman of the MAC at the Chambers explains; “People don’t apply to work at the Chambers – we actively go out and seek those that we know will fit in with us. We believe that we are unique in that everyone gets along.”

Simon Marsh trained at Trinity College, Cambridge and The Clinical School, Addenbrooke’s Hospital. He was awarded an MD by the University of Cambridge in 1996 and in the same year received the Intercollegiate Fellowship in General surgery.

He joined The London Breast Clinic at 108 Medical Chambers in 1999 and is now Lead Clinician at the Colchester Breast Unit, dividing his time equally between the NHS and The London Breast Clinic. He maintains an active interest in research and is an Honorary Senior Lecturer at Essex University where he has been responsible for setting up the Essex University MD programme for surgeons in training.

He is involved in the treatment of over 400 breast cancer patients each year. He is a Consultant Surgeon.

World-class care Given the wealth of expertise and research undertaken in the Chambers, ensuring the potential benefits of their work reaches patients as quickly

globalopportunityhealthcare.com

Issue 01

| Global Opportunity Healthcare Private Patients 2016

27

|

108 Medical Chambers

| 108 MEDICAL CHAMBERS THE LONDON BREAST CLINIC Investigation and treatment of breast problems l

THE LONDON SKIN CLINIC Assessment and treatment for suspicious moles and lesions as well as general dermatological conditions l

THE GILMORE GROIN & HERNIA CLINIC The original clinic for the treatment of groin pain and also herniae of all types l

THE LONDON RECTAL CLINIC Expert opinion and treatment of colo-rectal conditions from haemorrhoids through to inflammatory bowel disease l

THE LONDON SPORTS INJURY CLINIC Specialist sports doctor and physio to keep you out in the middle l

THE LONDON THYROID CLINIC Assessment and treatment of all thyroid and general ENT conditions l

as possible also remains critical. The access to genetic testing is one aspect of the Chambers’ work making significant waves internationally.

One prominent field of investigation has looked into the role of the BRCA gene. The BRCA genes are human genes that produce tumour suppressor proteins. As such, they play a critical role in ensuring the stability of the cell’s genetic material.

But some inherited mutations in the gene have been shown to increase the risk of female breast and ovarian cancer, as well increased risk for several other cancers.

“Dr James Mackay is the genetic oncologist member of our MDT (multidisciplinary team), investigating the BRCA gene in genetic and family trees,” Hamish explains. “This issue is particularly important in some countries of the Middle East so Dr Mackay sees a lot of patients from this region.

He can do his consultations via Skype through talking therapy, with blood samples then obtained locally and sent to be analysed as required.”

“This is where, across our profession, we are already ahead of the game when it comes to second opinions because much of our work can be done remotely. So our patient doesn’t have to travel if they really don’t need to.”

“This can help significantly cut initial cost at the beginning of the treatment process. A patient doesn’t even need to be in the country in order to have confirmation of a condition, as well as recommendations for treatment.”

Although continuous research and pioneering treatments are critical, their effectiveness is only as good as the consultants administering them.

Hamish explains; “A treatment doesn’t always need to be ground-breaking. But it must always be done properly. We must ensure the patient is always put at ease.” It is this commitment to a comprehensive

28

Global Opportunity Healthcare Private Patients 2016

| Issue 01

108 Medical Chambers

care package from that initial appointment, to follow up care and final discharge that is notably impressive.

The Chambers’ MDTs also play a crucial role in this respect in other specialist clinics and not just the breast team. “For example in the treatment of groin problems it’s not just about being excellent at surgery,” says Mr Marsh. “The whole team is very important - the anaesthetists, the physiotherapists and our sports injury specialists all come together.

“MDT meetings originated in the NHS. But in the private sector it’s about gathering experts in their field to make sure the diagnosis is right. That’s what we do – we make sure that everybody has thought about the whole host of treatment options.”

Speedy access Awaiting test results can often be an extremely anxious experience, and can be made worse if a patient has travelled from overseas for treatment in a relatively unfamiliar clinical environment.

“Our approach is to ensure there is always someone available,” says Hamish. “We are dealing with people who have problems – they may have serious anxieties, so the quicker they can be seen, the more we are able to minimise them.”

Immediate testing is just one aspect of treatment which can help put a patient’s mind to rest much faster, allowing them to begin their treatment as soon as possible. The Chambers’ 108 X-Ray and Imagining Centre provides rapid diagnostic breast investigation, using some of the latest medical technology – from 3D tomosynthesis digital mammography and ultrasound to and core biopsy under both ultrasound and x-ray imaging.

“If a patient finds a breast lump, they can be seen the same day and have all the imaging done on site straight away,” says Hamish. “When a patient is on site everything can be done within an hour. And if the imaging results doesn’t look quite right and a biopsy is needed, it can be done the same day with the results available within 48 hours.”

And after every biopsy undertaken, each case is referred to the Chambers’ expert MDT teams.

“Should we decide to repeat a biopsy we may find something different that changes our agreed treatment plan. This is the strength of having the whole team involved.”

And with the Chambers’ impressive international base, patients travelling from overseas can be confident in all aspects of treatment. “Due to the amount of international patients, our MDTs are specialists in many issues indigenous to particular regions around the world,” says Hamish.

“For example our dermatologists treat many patients from the Middle East and are familiar with certain conditions commonly found in that region.

This wide berth of knowledge and understanding speeds up access, giving our patients the best possible clinical experience throughout their entire treatment pathway.”

Further information www.108harleystreet.co.uk

globalopportunityhealthcare.com

Advanced Oncotherapy

|

Advanced Oncotherapy’s newest clinic in Harley Street will serve as a benchmark for cancer radiotherapy treatment with their next generation of proton beam therapy technology, as Dr Mike Sinclair, Executive Chairman at Advanced Oncotherapy (AVO) tells Jack Ball

Beaming into the future 30

Global Opportunity Healthcare Private Patients 2016

| Issue 01

H

istorically, conventional radiotherapy using X-rays (photons) has played a central role in increasing the survival rates of cancer diagnoses. According to Cancer Research UK, cancer survival rates have more than doubled in the UK over the last 40 years with half of all those diagnosed now surviving the disease for 10 years or longer.

X-ray radiotherapy is one of three modalities for cancer treatments, adopted either on its own (or in combination) with invasive surgery, or chemotherapy using highly powerful drugs to attack malignant cells. And whilst advancements in the effectiveness of these treatments have improved exponentially, the next generation of proton beam therapy available at Advanced Oncotherapy’s London Harley Street Proton Therapy Centre will offer potentially life saving cancer treatment.

With its location in one of the world’s most exclusive areas for private healthcare, the Centre will be the first location in the UK to use high-energy proton beam technology for the treatment of cancers.

“The problem with conventional X-ray radiotherapy using photons is that the treatment produces a certain amount of collateral damage in healthy tissue on either side or front and back of a tumour,” says Dr Mike Sinclair, Executive Chairman at AVO. “Charged protons are much more precise. We can

globalopportunityhealthcare.com

| now focus a proton beam down to the width of a human hair, reducing any immediate as well as longer lasting side effects.” This significant increase in clinical accuracy has many benefits. As protons do not pass through and into adjacent healthy tissue, proton beam therapy is particularly important for patients whose tumours are near sensitive organs like the heart, lung, liver, brain, oesophagus or spinal cord. This technology also represents a significant advancement in the treatment of cancers in children, whose organs are still developing and cannot sustain any collateral damage that may come as a result of standard X-ray radiotherapy treatment. Indeed, children with brain tumours, for example, can run a much higher risk of longer term complications when treated with standard photon X-ray radiotherapy, including hearing problems and impaired brain function post treatment.

DR MIKE SINCLAIR Dr. Sinclair qualified in medicine from the Middlesex Hospital, London in 1967 and held a number of appointments at teaching hospitals in London. He became a Registrar in Psychiatry at the Maudsley Hospital and Institute of Psychiatry of London University before entering business in 1971.

Between 1971 and 1977 he held senior board positions with Allied Investments Limited, which had operating interests in nursing homes through Nestor Nursing Homes, nursing agencies through the British Nursing Association, deputising services for doctors, medical equipment distribution, the management of hospitals for governments in the Middle East and the operation of a health spa.

He was also the chairman and founder of US-based Atlantic Medical Management LLP and is the Chairman of AIM traded company, Totally Plc. Mike was the founder and chairman of Lifetime Corporation Inc, a New York Stock Exchange listed company, which grew to become the US’s largest home healthcare company, employing 75,000 staff and operating out of 400 offices.

LIGHT system technology The technology used by Advanced Oncotherapy is based on the Large Hadron Collider at the European Organisation for Nuclear Research, or CERN, in Switzerland. The technology used at CERN relies upon a synchrotron style accelerator to form beams of concentrated protons, requiring vast amounts of infrastructure and extensive shielding through thick concrete walls and insulation – the Large Hadron Collider is built in a huge underground tunnel, which is one of the largest construction projects the world has ever known.

However, AVO’s LIGHT therapy system does not require either a cyclotron or synchrotron, allowing increased precision and control of the proton beam to target a tumour more directly and safely within a comparatively small facility.

“Our LIGHT system is made up of 15 modules to form a linear accelerator,” says Dr Sinclair. “Each module is the length of a medium to large dining room table, so you can actually deliver the entire system to the building with just four strong people.

The IT to control the accelerator and the beam can be simply carried through the front door.”

In addition to the reduced operating cost that comes from this manageable linear accelerator system, proton beam therapy has another unique

globalopportunityhealthcare.com

Advanced Oncotherapy

Left: Cross section of London’s Harley Street Centre Below: LIGHT (Linac for Image Guided Hadron Therapy) system

advantage for both patients and clinicians.

“If there are side effects from traditional X-ray therapy in 5, 10 or 15 years down the line, the lifetime costs of treatment can become significant,” as Dr Sinclair explains. “But with a lack of collateral damage from proton therapy, the lifetime cost can be greatly reduced. If you can bring down the capital cost and operating cost with a linear system, you can also reduce the lifetime cost for the patient and that’s a big advantage in terms of making this type of treatment affordable.”

Indeed, literature has shown that proton therapy can cut down the risk of developing secondary malignancies by up to 50 per cent. With AVO’s unique accelerator technology benefitting clinicians and patients alike, Dr Sinclair is optimistic that the number of those using proton treatments will only increase in the coming years.

Issue 01

| Global Opportunity Healthcare Private Patients 2016

31

|

Advanced Oncotherapy

| Above: AVO Sub-Basement Below: Treatment room Bottom: Harley Street Centre, London

AVO on Harley Street In 2015 AVO signed an agreement to lease a prestigious Harley Street location from the 90acre Howard de Walden Estate in central London.

“They approached us initially because they were keen to have a proton beam therapy treatment on the Estate,” says Dr Sinclair. “But a cyclotron or synchrotron proton beam machine would not have fitted. So our linear system was the only option, and in this particular instance there were two adjacent buildings available where we could effectively incorporate it.” Simon Baynham, Property Director at the Howard de Walden Estate, explains the Estate’s decision to approach AVO saying; “Such a facility should further enhance the tremendous work already being carried out in Harley Street, by some of the world’s top oncologists and radiologists in the field of cancer.”

“We are extremely excited that such a ground breaking and pioneering new facility is to be built in Harley Street, based upon the advances and research carried out at CERN.” In addition, the Proton Therapy Centre on Harley Street will be offering concierge services for overseas visitors including airport collection, hotel reservations and advice for patients at this particular challenging time in their treatment.

Advanced Oncotherapy

be installed in another UK city, in China, and so forth. Although there are roughly 16,000 to 17,000 radiotherapy rooms globally that use traditional X-ray radiotherapy technology, only 150 treatment rooms currently offer advanced proton therapy treatment. So increasing access both in the UK and internationally has been a central tenet of AVO’s vision moving forward.

“We are determined to make this treatment affordable. To open a facility for an extra couple of hours, particularly if an NHS hospital is providing the staff to operate it, poses no additional cost to the facility. But it does provide an extremely important service, in particular for children seeking treatment.” And as proton beam technology begins to enter the mainstream, there will be ever more opportunities for more healthcare organisations to access this next generation of treatment at a manageable price point. “The opportunity for the NHS and other similar government bodies around the world to acquire this technology will come sharply into focus when mass production begins to bring costs significantly down,” Dr Sinclair explains.

“To reduce the cost you have to manufacture at a low cost base and this is going to be an important step for us over the course this year. The biggest move forward will come when healthcare facilities begin to make decisions about whether to replace their X-ray radiotherapy machine with a proton therapy unit at a similar price.”

In terms of developing healthcare systems, the WHO’s 2014 World Cancer Report stated that more than 60 per cent of the world’s total new annual cancer cases occur in Africa, Asia and Central and South America with the regions accounting for 70 per cent of the world’s total cancer deaths.

As such, AVO’s next generation proton beam technology available at their new London Clinic will also play a unique role in shaping the future of cancer treatments worldwide.

Further information www.advancedoncotherapy.com

Increasing access AVO has a significant pipeline for installing this technology across the globe. After the first one is installed in Harley Street, other systems will

32

Global Opportunity Healthcare Private Patients 2016

| Issue 01

globalopportunityhealthcare.com/private patients

Royal Brompton & Harefield Hospitals Specialist Care

|

A global flagship for innovative heart and lung care Responsible for several major clinical breakthroughs, The Royal Brompton and Harefield NHS Foundation Trust remains one step ahead of the game in specialist heart and lung care, says David Shrimpton, Managing Director, RB&HH Specialist Care

W

ith our history spanning over 170 years, The Royal Brompton and Harefield NHS Foundation Trust (RB&HH) has a prestigious history like no other - renowned globally for our extensive expertise, research breakthroughs and superlative standards of cardiovascular and respiratory care. The Trust is made up of both the Royal Brompton Hospital in Chelsea, Harefield Hospital near Uxbridge and most recently an Outpatients and Diagnostics facility at 77 Wimpole Street in London’s prestigious Harley Street Medical Area.

All facilities boast many clinical ‘firsts’, firmly committed to pioneering cardiac and lung surgery, minimally invasive procedures and newer and more

34

Global Opportunity Healthcare Private Patients 2016

| Issue 01

effective treatments for those suffering from complex heart and lung problems.

A major breakthrough in 1983 saw Professor Sir Magdi Yacoub perform the UK’s first heart and lung transplant at our Harefield site, setting the hospital on its path to developing a globally renowned transplant unit. Amongst some of the highest success rates in the UK, over 3,000 transplant procedures have now been carried out since 1980.

This year saw another Trust ‘first’ when RB&HH Specialist Care opened their dedicated private outpatients and diagnostics facility at 77 Wimpole Street. Based in the heart of the Harley Street Medical Area, 77 Wimpole Street houses some of the world’s most advanced diagnostic equipment,

globalopportunityhealthcare.com

|

Royal Brompton & Harefield Hospitals Specialist Care DAVID SHRIMPTON David Shrimpton has been leading RB&HH Specialist Care for the Trust since May 2008. In his eight years of tenure, David has grown the Specialist Care department into a truly international offering, which now cares for patients from the Middle East, Russia, China and further abroad. In this time the revenue generated by the division has more than doubled, delivering important funding for the Trust, whilst providing international patients access to world leading heart and lung care.

Pioneering specialist care

internationally renowned consultants, nurses and clinical staff and serves as an extension to the world class specialist care already on offer.

As specialist hospitals we only provide treatment for patients with heart and lung disease, offering all manner of cutting edge treatments, including respiratory, thoracic, cardiology and cardiac surgery for both paediatric and adults. Everything we offer to our UK patients is open to our international patients as well. And having cared for international patients for such a long time, we understand that seeking medical treatment abroad can be daunting. Our dedicated Specialist Care team makes the treatment pathway as easy as possible, taking care of the patient’s needs throughout their entire stay with us.

globalopportunityhealthcare.com

The Hospitals’ specialism in lung disease dates back as far as 1841 for Royal Brompton, and the 1930s for Harefield Hospital – both initially treatment centres for tuberculosis patients. A testament to its pioneering care in the UK, support for both sites has been extensive, including that from the UK royal family and Charles Dickens, amongst others. In light of our ground-breaking work in the field of Cystic Fibrosis, HRH Prince Charles the Prince of Wales became patron of the Cystic Fibrosis Trust in its anniversary year in 2014.

Offering a range of cardiothoracic specialities across the Trust’s three sites, Royal Brompton and Harefield Hospitals is today the largest heart and lung centre in the UK, and among the largest within Europe. Central to the Trust’s continued success is our unique ability to attract the most talented clinical staff from across the globe, specialising in some of the most sophisticated treatments using state-of-theart diagnostic technology and treatment facilities.

Attracting patients from all corners of the globe, RB&HH Specialist Care work hard to ensure all sites are accessible to our international patients, with personalised care designed to ensure a comfortable stay. A concierge service provides practical support to patients and their families, paying particular attention to their cultural, religious and language needs. International patients have access to multifaith facilities, interpretation services, diverse menu options, as well as assistance in arranging transport, accommodation and medical appointments.

Internationally ranked research Clinical innovation and research are critical in any battle to fight disease. RB&HH is Europe’s topranked respiratory research centre and our cardiac, cardiovascular and critical care teams are rated in the top three most highly cited health research teams in Europe. Earlier this year RAND analysis of influential biomedical and health research showed that our researchers at Royal Brompton and

Issue 01

| Global Opportunity Healthcare Private Patients 2016

35

Royal Brompton & Harefield Hospitals Specialist Care

|

Harefield Hospitals had more highly cited papers on the topic of respiratory care than any other UK Trust, and tied highest for the number of papers specialising in cardiovascular medicine.

Our consultants have been responsible for many medical milestones, from performing the first heart and lung transplant in Britain, and founding the largest centre for the treatment of cystic fibrosis, to discovering the genetic mutation responsible for diluted cardiomyopathy.

Based at our Royal Brompton site, the Clinical and Genomics laboratory was developed from a transnational research project with the National Heart and Lung Institute at Imperial College London, leading to the development of a new gene panel that simultaneously tests 169 genes that are known to be associated with cardiac conditions.

RB&HH Specialist Care patients have full access to the Trust’s diagnostic testing facilities, including next-generation sequencing (NSG) to improve the diagnosis of inherited cardiac conditions (ICC) for families and individuals. These are a group of genetic disorders that affect the heart and major vessels, in particular the heart muscle (Cardiomyopathies), the heart rhythm (Inherited Arrhythmia Syndromes) and the aorta (Aortopathy) – in many cases these diseases can lead to sudden death at a young age, meaning expert diagnosis and management are an imperative.

Allowing significantly faster and accurate diagnoses of a multitude of cardiac conditions, the lab is already processing an impressive 1,000 samples for ICC per year with this number set to expand. Testing for Inherited Lung Conditions mirrors our continued ICC success, with a new gene panel having recently been developed which can test for 173 genes associated with a range of lung conditions and lung cancers. And while this panel is still in the process of being validated, our lab is once again one step closer to becoming a world leading centre for cardiac and respiratory genetic testing.

Continual medical milestones like these are only made possible through the revenue generated from the Trust’s private arm. Offering treatment to those who have private medical insurance or those who choose to fund their care privately means every single penny can be reinvested into the Trust to help the day to day running of our specialist heart and lung services.

Further information www.rbhh-specialistcare.co.uk Email: privatepatients@rbht.nhs.uk

36

Global Opportunity Healthcare Private Patients 2016

| Issue 01

globalopportunityhealthcare.com

| RB&HH Specialist Care in Harley Street

Royal Brompton & Harefield Hospitals Specialist Care

T

The Trust’s latest Outpatients and Diagnostics facility at 77 Wimpole Street opened in July 2016. The new premises in the heart of the Harley Street Medical Area bear more of a resemblance to the capital’s many boutique hotels, yet it is home to some of the world’s most advanced diagnostic equipment, internationally renowned heart and lung consultants, nurses and clinical support staff.

High ceilings and ornate features in bright and spacious waiting rooms offer a relaxing and comfortable environment, all designed to ensure a comprehensive and holistic patient environment.

And with the latest diagnostic and testing capabilities on hand, consultations and multiple tests can be scheduled on the same day, in one central London location, six days a week.

“Howard de Walden manages the Harley Street Medical Area, which in itself is a great brand,” says David Shrimpton, RB&HH Specialist Care Managing Director. “Combining the Estate, ourselves and other partners means we can achieve great things for private specialist care in London.”

The diagnostic capabilities at 77 Wimpole Street are extremely advanced and this requires the best equipment. The new facility now offers Rubidium Cardiac PET-CT, and is one of only two centres in the UK offering this advanced imaging technology.

The technology uses a Rubidium tracer which has a very short half life of 75 seconds, meaning a full diagnostic procedure can be completed in less than an hour (as opposed to four or more hours

using traditional SPECT imaging). The patient’s exposure to radiation is also dramatically reduced while increasing the procedural diagnostic accuracy – giving invaluable prognostic information to the consultant.

“If we are to continue to be a centre of excellence, we must be able to offer the very latest in clinical treatments such as PET,” says Wimpole Street’s General Manager Zohreh Palmer. “With this we are somewhat of a flagship in the very heart of Harley Street.”

With consultations and diagnostics all available on one site, this one-step approach at 77 Wimpole Street removes the burden of multiple appointments and unnecessary travel across different sites. The facility’s Patient Journey Co-ordinators also play a central role in ensuring a seamless experience for both referrer and patient - from registration and consultation all the way through to diagnostic testing and treatment.

Zohreh concludes; “We are proud that our new facility will continue to offer the very best in heart and lung care, giving patients and clinicians access to a one stop diagnostic centre with globally renowned consultants.”

Further information www.rbhh-specialistcare.co.uk Email: privatepatients@rbht.nhs.uk

SERVICES AVAILABLE: Respiratory and Cardiology Consultations PET-CT Imaging (cardiac, oncological and neurological) l CT (cardiac, lung and general) l MRI (cardiac and general) l Non-invasive

cardiology – Cardiac Monitoring Exercise Tolerance Tests, ECG l Echocardiography (stress & contrast) l Lung Function l Chest X-ray l

l

globalopportunityhealthcare.com

Issue 01

| Global Opportunity Healthcare Private Patients 2016

37

|

Schoen Clinic

Back to back

38

Global Opportunity Healthcare Private Patients 2016

| Issue 01

globalopportunityhealthcare.com

Schoen Clinic’s orthopaedic hospital in Harley Street Medical Area, specialising on total spine care, will be a London first with expert multidisciplinary and comprehensive care delivered by worldleading consultants in one single site, says Andreas Ludowig, Managing Director

C

|

Schoen Clinic

urrently running 18 highly specialist hospitals spread across some of the most beautiful landscapes in Germany, Schön Klinik has steadily become an industry leader in mental health, orthopaedics, neurology, surgery and internal medicine. Since its inception in 1985 the group has remained firmly committed to the most advanced levels of clinical specialisation, allowing clinicians to identify and innovate the most effective therapies for those seeking specialist treatment from all corners of the globe.

Testament to its success, the group is now the largest owner-managed clinic group in the German market, caring for over 101,000 patients every year. Former Soviet President Mikhail Gorbachev and most recently the Emir of Kuwait have been two of many prominent patients, drawn to the superlative standards of care on offer from world leading spinal surgeon and Medical Director, Professor Michael Mayer.

“Over the years, we have managed to establish an offering of highly complex treatments,” says Andreas Ludowig, Managing Director at Schön Klinik. “We began with mental health 30 years ago, but quickly moved into orthopaedics and neurology, spine and endoprosthetics. Now we feel that we have the experience and strength to bring our extensive expertise into different healthcare markets like London.”

As part of Schön Klinik’s vision for the next phase of expansion, 2017 will see the group bringing its unique concept of a highly specialised hospital to the capital’s famed Harley Street Medical Area – to join the ranks of some of the world’s most advanced private care facilities. Schoen Clinic London will offer world class orthopaedic and multidisciplinary care for varying degrees of complex clinical cases – all in one facility.

A ‘one-stop shop’ for total spine care With its unique concentration of world class practitioners located in a small area of London’s exclusive Marylebone, the Harley Street Medical Area offers a superlative environment upon which to bring Schön Klinik’s vision of a super specialist hospital within London to life.

“We saw our concept of a highly specialised hospital doesn’t yet exist here in London, the UK or in any other metropolitan areas in Europe. So we believe there is a demand for this level of specialist care from patients,” says Ludowig.

The scale of the group’s new facility is also remarkably impressive in size and scope of clinical expertise. “Our central concept is to provide a ‘one stop shop’ healthcare service,” Ludowig explains.

“Schoen Clinic London will house roughly 40 beds and will be a super specialised orthopaedic clinic

globalopportunityhealthcare.com

Issue 01

| Global Opportunity Healthcare Private Patients 2016

39

Schoen Clinic

|

focusing specifically on the spine. We will have all of our diagnostics and radiology facilities on site – the patient will be able to come in, get their diagnostics and leave with a specific treatment path.”

Schoen Clinic London will provide an intensive care unit, but should further issues arise that cannot be treated through the specialist orthopaedic and spinal care on offer, the Clinic will also cooperate fully with other local hospitals when required.

The Schoen difference In Germany the group is known for its high level of specialisation which comes with a unique approach to ensuring the highest levels of clinical quality and expertise.

Generally, consultants based in Harley Street split their time between their contracted practice within the NHS and their work within the private sector.

For example a consultant may practice in their NHS hospital three days a week, committing the other two to their chosen private facility in the area.

Schön Klinik, however, plans to offer a different model where the consultant can work full time for Schoen Clinic. The decision to offer fixed term contracts, bucking the norm found in other leading private clinics, stems from the company’s desire to firmly establish the highest possible standards and quality management. “In Germany we believe that when you have a dedicated team that is solely part of your organisation it becomes much easier to provide better quality – everyone signs up fully into the processes and the entire organisation.”

But all healthcare markets vary and models that may have proved successful in Germany may not necessarily translate directly into their entry into Harley Street. “We’re aware that coming from Germany to another foreign market requires some flexibility and knowledge about what’s needed in the UK market,” says Ludowig. “But where there is competition, there is also demand. And we’re not afraid of competition. In the last 30 years in Germany we went into metropolitan areas where there has always been competition.”

Quality measurement – the core of Schön Klinik

Interaction with research

From the early stages, Schön Klinik has focused on offering excellent healthcare and it is therefore not surprising that quality represents the core of the Schön Klinik group. In order to be able to constantly improve their medical care and treatment outcome, quality results are regularly reviewed and discussed in expert groups. The data collected covers the areas of patient experience, treatment outcome as well as patient safety. Treatment outcome covers both the patient reported outcome as well as the clinical outcome. This data is analysed regularly and used for quality improvement across all 18 hospitals.

The group is very proud of its extensive quality measurement and the incorporation of the results in their hospitals. But it is not just the group that deems this approach to offering better healthcare to be appropriate. In 2013 the renowned strategist Michael Porter published an article about Schön Klinik in

40

Global Opportunity Healthcare Private Patients 2016

the Harvard Business Review. The article titled ‘The strategy that will fix healthcare’ identified the group as an exemplar of patient centric health care provision and outcome measurement led quality improvement.

| Issue 01

Research and clinical quality go hand in hand – to offer the latest advancements in clinical treatments, activity in some level of clinical research is an imperative. “Even as a private hospital group, we interact very closely with universities,” says Ludowig.

‘Our team of dedicated liaison managers have specific in-depth knowledge and appreciation of the cultural needs of patients and their extended families.’

globalopportunityhealthcare.com

|

Schoen Clinic

ANDREAS LUDOWIG After finishing his business administration studies, Andreas Ludowig worked as a consultant at Booz & Company from 2001 to 2007.

After joining the Schön Klinik group he headed the department for corporate strategy and business development from 2009 to 2011. He then took over responsibility for Schön Klinik Roseneck with focus on mental health as managing director and in 2012 for Schön Klinik Bad Aibling, with a focus on acute neurology and neurological rehabilitation. In the beginning of 2016, Andreas Ludowig became managing director of Schön Holding SE & Co. KG with the task of advancing Schön Klinik’s offer for international patients in Germany and the UK. He is also responsible for the set up of new clinics abroad.

will bring this data for use in the UK and compare it with that from our British patients, together with academic work from a university hospital.”

The group also organises the chief physicians across its hospitals into expert groups – to come together and work on joint processes and quality standards. “Our expert groups hire people to establish a science office and undertake studies to support its work,” says Ludowig. “For example we’re now working with a professor at ETH Zurich, a world leading technology university. He is now able to support our science office in the area of spinal surgery.”

International focus

“Many of our hospitals adhere to the standards of teaching hospitals. And the group has a lot of professorships in Germany as well as very close links with leading teaching and research universities like the University of Munich and the University of Hamburg.”

The Clinic will also bring its continued research and data collection into its future activities in the UK – to better assess and measure clinical outcomes of their patients. “In Sweden, there is a Swedish spine registry where they document all spinal treatments performed,” Ludowig explains. “They use follow up questionnaires and surveys to establish how the patient is doing after six months. At Schön we have a large amount of patients that we focus on – with large amounts of data on hand. So we have also started gathering this data in much the same way, with follow up calls with patients every six, 12 and 24 months.”

This wide availability of patient data on hand is exceptionally useful for both researcher and clinician – data on this scale is generally not so freely available. “We compared our data with the Swedish Spinal Registry to see what we can learn from each other,” says Ludowig. “And over time we

globalopportunityhealthcare.com

UK patients usually don’t travel overseas for medical treatment, but the group has extensive experience in dealings with patients from across the globe – from countries such as Qatar, Saudi, Kuwait, UAE and Bahrain.

“Often a family may accompany a patient travelling to the UK for treatment, particularly if their time with us involves a prolonged stay,” says Ludowig. “Our team of dedicated liaison managers have specific in-depth knowledge and appreciation of the cultural needs of patients and their extended families. They work side by side with each group for the entirety of their stay with us and can accommodate all manner of requests.”

With the group’s international expertise, Ludowig is confident that Schoen Clinic London will fast become a leading healthcare figure in the Harley Street Medical Area. “There’s demand and there’s competition,” he concludes. “This offering of super specialised spinal orthopaedic treatment does not exist everywhere - so we can really prove that we can provide the most superlative levels of quality and care.”

Further information www.schoen-kliniken.com

Issue 01

| Global Opportunity Healthcare Private Patients 2016

41

Moorfields Private

|

Moorfields Private is the world’s leading destination for expert eye treatment and sets standards for the rest of the world to follow, says Maria Dimmock, Managing Director

Perfect vision M

oorfields Private is the London-based private division of the world-renowned Moorfields Eye Hospital NHS Foundation Trust. Since opening in 2004 it has gained a reputation as a centre of excellence for providing ophthalmic care to private patients from the UK and across the world. “For over 200 years Moorfields has pioneered research, employed the brightest minds and delivered visionary eye care, maintaining an unrivalled international reputation for research and cutting edge treatments,� says Maria Dimmock, Managing Director for Moorfields Private.

World-class care Moorfields Private has built its reputation as the preferred private provider of specialist ophthalmic care to patients of all ages who are referred to us from both within the UK and overseas. This,

together with the latest treatments for eyesight correction and consultants specialising in cosmetic eye treatment, enables private patients to access the most comprehensive range of private ophthalmic services available in the UK. The key ingredient is continuity of care, provided only by Moorfields consultants, supported by a team of specialist trained nurses and dedicated support staff. At every visit, patients will see their surgeon of choice who will lead every aspect of their care, from the first outpatient appointment to surgery and after care. All consultant ophthalmologists at Moorfields are on the Specialist Register of the GMC and several are leaders in their particular field, with roles that include advising the Royal College of Ophthalmology, acting as an examiner for other

42

Global Opportunity Healthcare Private Patients 2016

| Issue 01

globalopportunityhealthcare.com

|

vision professionals and advisers to visiting observing surgeons from all over the world.

A seamless pathway for overseas patients Moorfields Private offers a dedicated Patient Services Co-ordinator service for overseas patients, ensuring that each stage of the pathway is managed through one central point of contact.

This ensures that the team can arrange treatment around the patient’s travel arrangements, and provide ongoing communication with their Embassy or corporate sponsors and medical teams back home.

Consultations and diagnostic services take place in the newly opened Outpatient Centre in the hospital’s City location or in the Outpatient Centre at Upper Wimpole Street in the West End. Inpatient

globalopportunityhealthcare.com

Moorfields Private

treatment is undertaken in private en-suite facilities within our City hospital’s Admissions and Refractive Suites. Moorfields’ facilities are easily accessed from London Heathrow and are within a short distance of the West End. “Being part of the Moorfields heritage provides the reassurance that you will have access to world-class consultant eye specialists who provide treatment and care for private patients with a wide range of eye problems, from common complaints to the most complex eye health conditions that often require treatment not available anywhere else in the world,” says Maria.

Further information www.moorfields-private.co.uk

Issue 01

| Global Opportunity Healthcare Private Patients 2016

43

Anglo Medical

|

Medical Angel Karine Solloway from Anglo Medical is helping the world access the best of British private healthcare

I

f you were not native to the UK but wanted to access British private healthcare, where would you start? Where can you find the best doctors and hospitals? How can you get an appointment with them? And will you even understand what they say?

One person who knows just how worrying and confusing it can be to navigate foreign private healthcare is Karine Solloway. For the past eight years she has been helping expats and foreign nationals living in the UK to find the right treatment, with a complete health concierge service through her company Anglo Medical.

Chance meeting A decade ago Karine had no experience in healthcare, nor any designs on the industry, but a chance meeting with an executive of HCA Group in 2008 changed everything. Impressed with Karine’s connections, the executive made her an offer she couldn’t refuse – to spend five days a month promoting their services to the Russianspeaking world.

Eight years on, those five days a month have grown to a full time business; one Karine feels very passionately about.

Russian-born Karine has lived in the UK for 26 years, but her Russian language and cultural understanding have made Anglo Medical a favourite with affluent Russian speakers who live or work in London, and Russians who travel to London frequently. And to Karine’s knowledge, it is still the only company that actively promotes British private healthcare to the Russian-speaking world on a daily basis.

But while she now has a thriving business with

44

Global Opportunity Healthcare Private Patients 2016

| Issue 01

a bulging portfolio of happy clients, things weren’t always so easy. Initially, she found herself in a territory that was extremely challenging. London hospitals and the majority of providers didn’t want to know about the Russian market – they were doing well enough with the Middle Eastern market and couldn’t see the point in investing time and money in an unknown territory such as Russia.

Winning over Russian clients It was also tough winning over Russian clients. She discovered that most Russian people who were otherwise quite well informed, were unaware that Britain had private healthcare, let alone that it was world-beating (all they had heard was bad news about the NHS).

Common misconceptions around the reasons for choosing a doctor were also a problem, but Karine has been able to reassure her Russian clients that British doctors only have the patients’ interests at heart, rather than financial gain. Karine is proud to work with doctors who value their own ethics,

globalopportunityhealthcare.com

|

Anglo Medical IMAGE: WWW.SHUTTERSTOCK.COM

and this professionalism extends to her own relationships with her clients.

Strong advocate for clients And her hard work and commitment has paid off.

Over the years she has won over both patients and doctors, and today the majority of her business comes through word of mouth.

Along the way she cleverly established the brand name Polyclinica to resonate with Russian imagination and attract and reassure patients.

Doctors also quickly learned that Karine could deliver. Indeed, today she has almost 3,000 patients on her books. And her business has grown, even through the sanctions, the drop of the exchange rate and numerous economic challenges.

The service Anglo Medical provides their patients is second to none. Karine is a strong advocate for her clients, ensuring their voices are heard and needs are met. And if they are not satisfied with their medical treatment or service, she is happy to tell their doctor.

globalopportunityhealthcare.com

KARINE SOLLOWAY Karine is a passionate humanitarian inspired by bringing positive change into people’s lives. She has lived and worked in the UK for over 20 years, originally providing stress counselling.

Finding the UK healthcare system difficult for a foreigner to navigate, she was inspired to create a bespoke service, patient and family-focused.

Her vision was to provide fast, stress-free access to specialist medical care, leveraging her extensive relationships with top UK consultants and specialists.

Ask about her dreams and aspirations and Karine will tell you she’s living them now.

Issue 01

| Global Opportunity Healthcare Private Patients 2016

45

|

Anglo Medical

|

Anglo Medical

Trusted environment

‘Karine is a strong advocate for her clients, ensuring their voices are heard and needs are met.

And if they are not satisfied with their medical treatment or service, she is happy to tell their doctor.’

The complete package Whether her patients live in the UK or travel here specifically for healthcare, Anglo Medical offers a complete package that includes everything from visa support, accommodation, airport transfer, chaperone and door-to-door escort, to accompanying them through their entire hospital experience, consultations, interpreting and translating medical documents.

They even check and translate medical bills to ensure no mistakes have occurred. It’s a service that is designed to be reassuring, and take away the stress of dealing with a new experience and working out different options and challenges.

Thanks to her ongoing, trusted relationship with many top consultants, Karine can also help customers see a specialist at short notice. She is personally on call around the clock for her clients and even sleeps with her phone. The majority of her doctors are also on call day and night if they’re needed, too.

While Karine may have begun her healthcare career helping Russians, she welcomes clients of any nationality who live in the UK or wish to travel there for private medical treatment.

Empathy and trust are Karine’s key principles, and she understands how vulnerable people feel around their health, especially in a foreign country.

That’s what makes her service so special – it’s not just about helping people find the best specialist or treatment, but cocooning them and their families in a trusted, knowledgeable and caring environment.

Thanks to her success, Karine no longer advertises her services; she doesn’t need to.

Instead she informs people about the doctors she works with, and welcomes new clients recommended to her by one of her thousands of happy patients.

It’s an approach that is clearly working, and one that could extend into the English-speaking market.

As times change, more affluent British people are looking at simplifying their already complicated and busy lives. Concierge services have sprung up and medical services are an obvious next step, especially where more complex and live disturbing surgeries and procedures are involved. With her wealth of knowledge and compassionate attitude, Karine looks forward to helping many more clients access world-class private healthcare in Britain in future.

Further information www.anglomedical.com

IMAGE: WWW.SHUTTERSTOCK.COM

46

Global Opportunity Healthcare Private Patients 2016

| Issue 01

globalopportunityhealthcare.com

HCA International

|

Excellence in private care Home to one of the world’s of the most vibrant healthcare markets, London has some of the most advanced private hospitals covering all manner of specialist care, says Khadija Mouhajer, Director of International Business and Relations at HCA Healthcare UK

A

s a recognised international centre of excellence, HCA Healthcare UK operates six world-renowned hospitals as well as a range of outpatient and diagnostic centres in and around central London, offering world-class treatment to private patients both from the UK and overseas. The hospitals include The Harley Street Clinic, The Lister Hospital, London Bridge Hospital, The Portland Hospital, The Princess Grace Hospital, The Wellington Hospital, The London Oncology Centre, Harley Street at UCH Cancer Centre and The Sarah Cannon Research Institute.

HCA Healthcare UK is part of The Hospital Corporation of America (HCA). Founded in 1968 and based in Nashville, HCA owns and operates 166 hospitals and employs approximately 225,000 people in 20 American states and in the UK. HCA Healthcare UK is a leading provider of cutting-edge treatment across its networks of facilities in London and Manchester, which include partnerships with leading NHS hospitals. Providing the best quality care to patients is at the heart of everything that HCA does. Maintaining the highest standards, driving growth and ensuring that patients and consultants continue to choose HCA requires a commitment to continuous improvement. HCA Healthcare UK’s success is built on sustained investment with more than £500m invested into its facilities and our people in the last decade, with a focus on new technology and innovations in complex care to further improve our standards of excellence. As the only UK private hospital provider with the highest level of intensive care in all our hospitals, we can provide care for patients of all ages and treat everything from the most straightforward conditions to the most complex and often life-threatening illnesses.

48

Global Opportunity Healthcare Private Patients 2016

| Issue 01

KHADIJA MOUHAJER Khadija is a senior executive with extensive international experience in the healthcare industry. She is HCA International’s Director of Business and International Relations, with responsibility for all operational and strategic development and relations in the international markets.

Khadija’s healthcare career spans over 19 years in both the public and private sector and includes all aspects of hospital management, international business development, medical tourism and business revenue growth and expansion. Khadija’s leadership has significantly grown the international market for overseas patients into HCA hospitals to 25 per cent of total business and contributed to the London economy through medical tourism.

globalopportunityhealthcare.com

|

HCA International

IMAGE: WWW.SHUTTERSTOCK.COM

globalopportunityhealthcare.com

Issue 01

| Global Opportunity Healthcare Private Patients 2016

49

HCA International IMAGES: WWW.SHUTTERSTOCK.COM

| HCA Healthcare UK has once again been honoured by winning one of the highest awards for British business: the Queen’s Award for Enterprise in International Trade in 2014. HCA was chosen for outstanding achievement in investment and growth of overseas business.

HCA Healthcare UK previously won the Queen’s Award for Enterprise in International Trade in 2004 and again in 2009, and will hold the 2014 Award until 2019. HCA Healthcare UK also won the IMTJ Medical Travel Awards for 2014 as the Specialist International Patient Centre and in 2015, The Wellington Hospital’s Acute Neurological Rehabilitation Unit was chosen as the Specialist International Patient Centre, and the IMTJ Award for 2016 recognised HCA Healthcare UK as the International Cancer Centre of the Year.

Overseas patients

“Most of our overseas patients are sponsored by their governments, and each referral is managed by the London-based medical health office of countries including Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and United Arab Emirates,” says Khadija Mouhajer, Director of International Business & Relations at HCA Healthcare UK. “We also treat patients from all over the world, namely Greece, China, Pakistan, Russia and countries in sub-Saharan Africa such as Ghana and Nigeria.”

50

Global Opportunity Healthcare Private Patients 2016

| Issue 01

Currently in the Middle East there is a massive drive towards improving healthcare and education, including building more hospitals, outpatient and diagnostic centres and medical research centres. In the meantime, Middle Eastern patients sponsored by their embassies are assessed for treatment at home. Once they have been diagnosed, a medical committee in the country of origin will decide if the treatment is available in their own country, or whether the patient needs to be sent abroad for further investigations and treatment.

Patient assessment

“Once a patient’s file has been sent to the medical health office, the chosen hospital (which is based on the required treatment and consultant’s expertise) is contacted to make the necessary arrangements.

Many of our consultants also hold senior positions in leading NHS teaching hospitals, thereby ensuring their patients have a quicker access to the latest diagnostic and treatment technologies in the private sector,” says Khadija.

Within HCA Healthcare UK, the majority of overseas referrals are sent to the international team to assist in managing the patient’s appointments outpatient/admissions as they support the patient and their relatives from the moment they arrive in the UK to the moment of their discharge.

globalopportunityhealthcare.com

| HCA Healthcare UK has established, and continues to maintain, good working relationships with many of the overseas health authorities.

“I have regular meetings with International Ministries of Health and their teams who are part of the Overseas Medical Committees,” says Khadija.

“We also participate in Visiting Doctors Programmes that help our consultants maintain good relationships with the treating consultants in the Middle East (i.e. developing clinician-toclinician relationships). As part of the Visiting Doctors Programmes, some of our consultants travel overseas for about a week, where they hold outpatient clinics, perform surgeries and give lectures.

“I myself travel to the Middle East frequently and when necessary meet with senior members of the management and eminent consultants to maintain ongoing relationships with International Health Authorities, establishing new links with hospitals and diagnostic centres to streamline a patient’s journey and to establish new discharge destinations for some of our complex patients, thereby remaining patient-focused at all times,” says Khadija.

“Although we do not actually manage any hospitals in the Middle East, we continue to maintain a presence by attending regular meetings, ongoing doctors visiting programmes, and exhibitions where we promote our services.”

NHS involvement

HCA Healthcare UK has also developed joint ventures with various NHS Trusts such as University College Hospital London at Harley Street, The

HCA International

London Gamma Knife Centre, St Bartholomew’s Hospital in London, a private patient centre at the NHS Queen’s Hospital in Romford and The Christie Clinic, a state-of-the-art private patient unit developed together with the internationally renowned Christie cancer hospital in Manchester.

Khadija believes the reputation of the NHS in the Middle East is a huge attraction to overseas patients visiting the UK and HCA Healthcare UK hospitals. “Many of our overseas patients and the international health offices in the UK are aware of the expertise and ongoing research efforts within the NHS. We have over 3,000 consultants at HCA hospitals and diagnostic centres, and the majority of those consultants hold senior positions within NHS teaching hospitals,” she adds.

While the UK continues to receive patients from the Middle East, Khadija believes that the volume of private patients has dropped over the last couple of years. This is due to increased international medical tourism and market efforts from countries such as Germany, Malaysia, South Korea, Thailand, USA and the UAE. “We still have an excellent reputation and treat complex cases despite the increasing number of international competitors,” says Khadija.

The international team

Khadija has recently set-up teams of International Patient Coordinators headed by International Relations Managers in each of the HCA Healthcare UK Hospitals and diagnostic centres. It is the role of the International Patients Departments to assist in streamlining the patient’s journey with the clinical teams. The International Patients Coordinators in the department will care for each and every patient on an individual basis from the moment of their arrival into the UK to the point of discharge.

The team is trained to understand each patient’s cultural needs and ensure they and their families feel well cared for and comfortable in their surroundings. Special considerations include religious requirements, food requirements and other cultural needs, which not only contribute to the patient’s personal experience but also help ensure the best possible outcome of their treatment, are readily available.

“I still cannot forget the words of the tour guide, when I first came to London as a tourist, “ recalls Khadija. “I went on a London Bus Tour and remember driving down Harley Street, where the tour guide said: “Ladies & gentlemen, this is the most renowned medical street in the world, consisting of specialist consultants and their clinics. For decades, patients have been coming to this street, not only from the UK, but from all over the world to seek expert treatments and consultations from London’s leading consultants.”

And the reputation of Harley Street as a centre of private medical excellence is still as strong today.

Further information www.hcahospitals.co.uk

globalopportunityhealthcare.com

Issue 01

| Global Opportunity Healthcare Private Patients 2016

51

Professor Anthony Goldstone CBE

|

A new future for the treatment of Multiple Sclerosis?

Pioneering research into haematology is informing new approaches to the treatment of MS. Co-located in one of the UK’s leading NHS teaching hospitals, Harley Street at University College Hospital continues to work with pioneering consultants to advance treatments, as Professor Anthony Goldstone CBE tells Jack Ball

N

ew methods in treating Multiple Sclerosis (MS) have been reported in recent months, with years of research leading to a breakthrough in understanding this condition.

One of the latest pioneering developments has been the use of stem cell transplantations, predominantly used to treat blood cancers and now being used to treat MS patients with promising results.

Harley Street at University College Hospital, part of HCA Healthcare UK, is the first private facility in the UK to offer stem cell transplantation for MS patients.

The JACIE-accredited (The Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and the European Group for Blood and Marrow Transplantation (EBMT) facility has been providing stem cell transplants for cancer

52

Global Opportunity Healthcare Private Patients 2016

| Issue 01

globalopportunityhealthcare.com

|

Professor Anthony Goldstone CBE

IMAGE: WWW.SHUTTERSTOCK.COM

globalopportunityhealthcare.com

Issue 01

| Global Opportunity Healthcare Private Patients 2016

53

Professor Anthony Goldstone CBE

|

patients for the last 10 years and has developed a comprehensive world class service, which has now been extended to MS patients.

How it works This treatment has been pioneered following years of research and advancements in cancer treatment, which has ultimately led to this technique being used to treat other autoimmune conditions.

Autologous stem cell transplant is a process in which the patient’s own stem cells are used to ‘reset’ the immune system and stop it from attacking the body. Patient’s stem cells are collected from the peripheral blood known as ‘harvesting’; these cells are then frozen until they are required. Patients enter the hospital and are given a high dose chemotherapy and antibody treatment which wipes out the patient’s bone marrow and immune system.

At this point the frozen stem cells are thawed and reinfused into the patient.

Globally renowned as one of the world’s leading haematologists, Professor Anthony Goldstone CBE, Medical Director at Harley Street at University College Hospital, has devoted more than 40 years to this area of medicine.

As part of the medical team who carried out the first autologous transplant at University College Hospital in the 1970’s, and a prominent consultant in the ongoing advancements in this treatment technique, he has first-hand experience of how stem cell transplants have transformed over the years.

“In 1979 the risk rate of not surviving this procedure stood at 20 per cent. Today it stands between just 2-3 per cent, ten times less risky

54

Global Opportunity Healthcare Private Patients 2016

| Issue 01

through various evolutions of the process” explains Professor Goldstone. “As such, it is now the standard treatment in serious haematology units like Harley Street at University College Hospital, for mostly haematological malignancies but also some solid tumours, and is established in both adult and paediatric medicine.”

One of the key components of this MS treatment is chemotherapy, an area where Professor Goldstone has played a pivotal role in developing doseescalated chemotherapy. Chemotherapy drugs are used to attack a malignancy, or the immune system in a case of MS treatment, in one of two ways. A single agent approach uses one chemotherapy drug while a multi-agent (combination chemotherapy) approach uses several different types of drugs, normally reserved for treatment during the latter stages of a disease.

“In the modern era of combination chemotherapy you could only escalate the combined drugs to a ‘ceiling’ point of dosage,” explains Professor Goldstone. “At this point the normal bone marrow could not tolerate any further rise in the amount of drugs administered. Moving past this ceiling would cause the patient to become ‘pancytopaenic’, meaning all healthy red and white cells, as well as platelets, would also be destroyed.”

A significant depreciation of healthy cells at this ‘treatment ceiling’ places any patient at enormous risk. As such more aggressive chemotherapy treatment that may be required during the advanced stages of a disease is no longer feasible.

Developed over the past 30 years, dose escalated or high dose therapy using stem cell transplantation aims to reduce such risk, allowing higher doses of the required drugs to be safely administered and

globalopportunityhealthcare.com

|

Professor Anthony Goldstone CBE PROFESSOR ANTHONY GOLDSTONE CBE Professor Anthony Goldstone CBE is a world renowned Consultant Haematologist, specialising in adult leukaemia, lymphoma and myeloma and other non-malignant haematological conditions.

He founded the transplant unit at University College Hospital (UCH) in 1979, and introduced an ambulatory cancer care model at UCH which set a national precedent in care standards.

Professor Goldstone was UCLH’s first Medical Director from 1992 to 2000. He was also the Director of the North London Cancer Network from 2000 to 2009.

He is the President of the Society of Hematologic Oncology (SOHO) and in the UK is a Past President of the British Society of Haematology and founder and Past President of the British Society of Blood and Bone Marrow Transplant. Internationally, Professor Goldstone was the founder and Chair of the European Society for Blood and Marrow Transplantation (EBMT) Lymphoma Group and founded its Registry. He has also given education sessions at the American Society of Haematology and at the American Society of Clinical Oncology.

managed. As Professor Goldstone explains, “Stem cells that make healthy bone marrow are skimmed from the blood taken from a patient and then frozen. Once a high dose of chemotherapy is given, the stem cells are thawed and given back to the patient as a blood transfusion.”

An influx of healthy stem cells means a patient can regrow any destroyed healthy cells at a much quicker rate, normally between 10-14 days. This allows a safe recovery from extreme doses of chemotherapy that would otherwise not be possible. Harley Street at University College Hospital utilises chemotherapy drugs in a similar fashion to treat MS, with high doses of chemotherapy used to destroy harmful cells in the immune system, so it no longer attacks the brain and spinal cord which causes further damage and the disease’s debilitating symptoms.

Access to treatment

‘In 1979 the risk rate of not surviving this procedure stood at 20 per cent. Today it stands between just 2-3 per cent, ten times less risky through various evolutions of the process.’

globalopportunityhealthcare.com

Harley Street at University College Hospital offers advanced treatments led by a team of internationally renowned consultant experts. “We are an independent private provider operating inside an NHS teaching hospital and are working to the same standards,” explains Professor Goldstone.

“The experience of stem cell transplant in London at Harley Street at University College Hospital is as high as anywhere in the world.”

Further information To find out more visit http://www.harleystreetatuch. co.uk/multiple-sclerosis-stem-cell-transplant/

Issue 01

| Global Opportunity Healthcare Private Patients 2016

55

The Christie Clinic

|

A cancer treatment powerhouse Dedicated solely to the treatment of cancer, The Christie Clinic is the world’s best unknown hospital, says Professor Sarah O’Dwyer, Clinical Director of the Christie Clinic 56

Global Opportunity Healthcare Private Patients 2016

| Issue 01

globalopportunityhealthcare.com

|

The Christie Clinic

PROFESSOR SARAH O’DWYER Sarah O’Dwyer is a highly experienced consultant surgeon with an international reputation for her work in the areas of colorectal disease and peritoneal malignancy. She is a graduate of the University of St Andrew’s and The Victoria University of Manchester.

She was awarded a Research Fellowship at Harvard University, USA, and travelling Fellowships to New South Wales, Australia, The Mayo Clinic and Minneapolis USA. Her first consultant post in 1992 was at The University Hospital Trust, Birmingham, and she took up her current post at The Christie in 1995.

Over the last 15 years Sarah has developed the colorectal team at The Christie from a single practitioner to a team of six consultants which provides a national service for peritoneal surface malignancy, and lead specialist multidisciplinary teams (MDT) for pelvic, colorectal, peritoneal and anal cancers. Their work in the field of colorectal peritoneal metastases was awarded Cancer Care Team of the year in the BMJ Awards and Macmillan in 2013.

L

ocated just south of Manchester in the North of England, The Christie NHS Foundation Trust is today the largest single site cancer centre in Europe, treating approximately 44,000 patients a year. The Trust houses the UK’s largest chemotherapy unit and one of the world’s largest radiotherapy departments – responsible for numerous clinical breakthroughs and ‘world firsts’, that have impacted the scope and direction of cancer treatments over the last 100 years.

The Christie is an international leader in the field of research and clinical development, employing over 2,600 staff across its services. This includes the largest single-site early phase clinical trial unit in the world, and one of the largest trial portfolios in the UK, with over 600 active clinical trials open. The hospital is also ranked as the ninth most technologically advanced cancer centre in the world.

In 2006 The Christie partnered with The University of Manchester and Cancer Research UK to form The Manchester Cancer Research Centre. This brings together research and clinicians to find better, more effective and personalised treatments.

The Christie is one of only two centres in the UK to be awarded Cancer Research UK status for excellence in cancer care. Coupling this with the groundbreaking work in clinical trials gives patients access to breakthrough drugs and the latest cancer treatment, with 26 per cent of patients travelling from across the UK for their cancer care.

globalopportunityhealthcare.com

Issue 01

| Global Opportunity Healthcare Private Patients 2016

57

The Christie Clinic

|

The Christie Clinic Regarded as an innovator, The Christie broadened its ambitions to consider a partnership with a private provider, to deliver quality cancer care to private patients, widening the scope of the offer in Manchester and cementing The Christie’s position as a destination for patients from across the UK and the globe. In September 2010 HCA Healthcare UK and The Christie joined forces and The Christie Clinic was formed.

HCA Healthcare is the largest provider of private cancer care in the UK and has a reputation for delivering acute care in a private setting. This joint venture means that private patients can be treated at a leading cancer centre, whilst raising resources for the NHS that can be reinvested back into services.

Claire Smith, Chief Executive Officer, HCA Healthcare UK Joint Ventures, says “The Christie Clinic is the first of its kind in the North-West.

Through The Christie Clinic we are able to support patients throughout their cancer journey and in one place – from diagnostics, surgery, chemotherapy, radiotherapy and beyond. The strength of the partnership has also enabled us to open a dedicated haematology bone marrow transplant unit.

“Providing a patient with a seamless pathway at what can be a very unsettling and emotional time is something we strive to do across all of our joint ventures, and we are extremely proud and privileged to be working in partnership with the Trust. Our shared commitment to delivering the highest quality patient care is helping to broaden the range of care available in Manchester whilst generating significant financial income for the NHS.” Professor Sarah O’Dwyer, Clinical Director at The Christie Clinic adds “We explain the partnership to all of our patients who have private insurance and might have otherwise used the NHS. They actually feel very comforted by the fact they can use their private health insurance whilst still contributing to NHS resources, and ultimately benefiting NHS patients.”

58

Global Opportunity Healthcare Private Patients 2016

| Issue 01

globalopportunityhealthcare.com

|

The Christie Clinic

Specialist treatment As a specialist cancer facility The Christie Clinic offers treatment for solid tumours and blood cancers, with a comprehensive pathway onsite for diagnosis, surgical intervention, chemotherapy, radiotherapy and stem cell and bone marrow transplant.

Being based onsite at The Christie means that patients can have treatment for complex cancers, “We provide some very highly specialised services” says Professor O’Dwyer. The Clinic performs surgery for rare cancers, particularly in the lining tissue of the organs in the abdomen, where rare tumours can develop. “We are one of only two centres in the UK licensed to carry out this treatment – consisting of a mixture of pioneering surgical techniques and chemotherapy in the abdomen. We develop those

‘The Christie Clinic is mindful that for patients who may have travelled from overseas for treatment, this can be a very difficult time; particularly as many may be unfamiliar with the UK and the treatment process when they arrive.’ techniques to translate into treatment for more common cancers that can spread in the area where peritoneal cancers normally locate.” adds Professor O’Dwyer.

Pioneering new treatments for rare cancers means that The Christie attracts referrals from across the world. “We have had overseas visitors who visit us to learn about what we do and how we do it – our surgeons have even performed surgery during a live operation educational event in Chennai India.”

Holistic cancer care A cancer diagnosis is a life changing experience for any patient and has a significant emotional and psychological impact. Holistic care allows all needs of a patient to be assessed and addressed accordingly, not just their physical illness and ‘cancer treatment’, but their emotional and psychological needs too. “We don’t just carry out an operation or give chemotherapy,” Professor O’Dwyer explains. “We have the entire support network for those patients who are treated here, whether that is as a private patient or NHS patient.”

In order to provide holistic cancer care a multidisciplinary team of specialists come together to continually review and adapt treatment plans.

“We invite all our different cancer specialists to come together, at the same time in the same room – to discuss the best course of treatment specific

globalopportunityhealthcare.com

Issue 01

| Global Opportunity Healthcare Private Patients 2016

59

The Christie Clinic

|

The Christie Clinic

|

‘In terms of nursing care, The Christie Clinic is focused on delivering excellent standards and ensures that nurse to patient ratios allow for this.’ to your case,” Professor O’Dwyer explains. “Safe and effective care in the best possible environment is what our patients are looking for. And we have a host of clinical support structures in place including MacMillan Cancer Support and complementary therapy support; this means our patients are given that extra level of care.”

In terms of nursing care, The Christie Clinic is focused on delivering excellent standards and ensures that nurse to patient ratios allow for this.

“Our level of nursing care means there is always someone who can answer any questions – to reassure and look after our patients from the very beginning until the very end of their journey with us,” says Professor O’Dwyer.

Oonagh McGugan, Clinical Services Manager at The Christie Clinic, echoes this sentiment; “We are committed to providing high quality healthcare and in order to do this we ensure that our nurse to patient ratios are reviewed daily. This allows us to

60

Global Opportunity Healthcare Private Patients 2016

| Issue 01

make sure we have the right levels of staff to deliver safe and effective care, where clinically necessary we can even provide 1:1 nursing care, for patients who are very unwell.” The nursing team includes Clinical Nurse Specialists who are skilled in particular tumour groups, this means patients have an expert nurse to answer any questions and offer support and guidance throughout treatment.

The Christie Clinic is mindful that for patients who may have travelled from overseas for treatment, this can be a very difficult time; particularly as many may be unfamiliar with the UK and the treatment process when they arrive. “Being in a different country and culture can be very frightening, let alone being in a hospital environment. We are aware that international patients may need additional support, and we can arrange for interpreting and other services to ensure patients are fully informed and supported at all stages of their treatment with us” says Oonagh.

This supportive care doesn’t end after treatment, with patients having continued access to nurses and the clinical team “even if a patient has had successful treatment, they can always phone further down the line,” Oonagh adds. With this dedicated approach to care it is unsurprising that patients regularly score these services as excellent in satisfaction surveys.

Research and partnering overseas

The Christie is committed to developing long term strategic partnerships and has even partnered with hospitals overseas to develop new and more

globalopportunityhealthcare.com

|

The Christie Clinic

| ‘Holistic care allows all needs of a patient to be assessed and addressed accordingly, not just their physical illness and ‘cancer treatment’, but their emotional and psychological needs too.’ effective services under the mentorship of teams with extensive experience in innovative treatment and research. “We can show them very detailed, long, procedures that take about 10 or 12 hours,” Professor O’Dwyer explains. “When it was first introduced people said there were too many complications. But our results have proved that this simply isn’t the case. If you have a team that can deliver treatment safely, they can then move on to teach others – avoiding a long learning curve with potential causalties along the way. This is one of the real advantages of partnership. It’s all about ensuring the correct selection and getting the right patient in the right place with the best possible team.”

The Christie recently partnered with the Madras Institute of Orthopaedics and Traumatology (MIOT) in Chennai, South West India – to help further develop its cancer care provision in a

62

Global Opportunity Healthcare Private Patients 2016

| Issue 01

The Christie Clinic

better organised and efficient way. Professor O’Dwyer explains; “MIOT is a unique setup in India, established by an entire family. The father was an orthopaedic surgeon who worked in the NHS, before returning to India to open this hospital. Aware of The Christie’s success, he wanted to adopt some of our care delivery concepts. And he’s very much modelling the care process on the standards of The Christie, including expert multidisciplinary teams.”

With innovation and breakthrough treatments comes fresh hope for patients living with cancer.

“The most important thing for any patient is successful, safe treatment in the best possible environment,” concludes Professor O’Dwyer.

Combining world class research, expert multidisciplinary teams and holistic treatment at the UK’s largest single site cancer facility means that NHS, private and international patients can receive the best possible care.

Further information If you would like further information about private patient services at The Christie Clinic please contact: info.christieclinic@hcahealthcare.co.uk +44 (0)161 918 7296 www.thechristieclinic.co.uk If you would like further details about The Christie’s international work, then please contact: Email: sophie.kennedy@christie.nhs.uk Tel: +44 (0) 161 918 7099 www.christie.nhs.uk

globalopportunityhealthcare.com

Healix Health Services

|

Accessing UK private healthcare solutions Healix Health Services’ bespoke medical case management solutions are helping overseas insurers and employers access, manage and oversee their medical claims and overall healthcare provision in the UK at preferential rates, says Richard Saunders, Sales Director at Healix Health Services 64

Global Opportunity Healthcare Private Patients 2016

| Issue 01

W

ith millions of people travelling across the world, whether for work or for leisure, finding the correct solutions to ensure they receive appropriate medical care whilst away from their home country can be challenging. Founded in 1992 by two leading experts in international healthcare delivery, Dr Peter Mason and Dr Paul Bevan, the Healix Group of Companies provides bespoke healthcare and risk management solutions to clients across the globe. Headquartered just outside London, the group boasts a medical team of more than 90 fully qualified doctors and nurses in the UK alone. “Healix Health Services is part of the Healix Group and acts as a specialist third-party medical claims administrator for domestic and international

globalopportunityhealthcare.com

|

Healix Health Services

RICHARD SAUNDERS Richard Saunders has worked in general insurance for over 30 years, with the last 17 spent in the healthcare sector, in roles encompassing business development, consultancy and sales.

He joined Healix in 2006 as Business Development Director, responsible for developing the corporate healthcare and third-party medical claims markets for Healix Health Services, as well as exploiting opportunities for the rest of the Group.

His achievements have included establishing Healix Health Services in the UK as the leading provider of self-funded corporate Healthcare Trust schemes and the only credible, independent medical claims ThirdParty Administrator (TPA).

IMAGE: WWW.SHUTTERSTOCK.COM

insurers, providing independent access to the UK private healthcare system and expert management of medical claims,” says Richard Saunders, Sales Director at Healix Health Services. “We are now the largest, independent medical Third Party Administrator (TPA) in the UK, also acting as medical administrator for approximately 20 per cent of all UK self-insured corporate healthcare trusts.”

Healix Health Services offers distinct propositions

to two different markets: overseas and domestic insurance companies looking for access to Healix’s provider network and management of their UK medical claims; and overseas and domestic employers (and some foreign governments) seeking a company to manage the medical treatment of their staff (people) whilst in the UK. With access to over 22,000 specialists across the UK, Healix can advise, authorise and provide access to medical treatment within the private sector, including NHS Trusts private services if this is where the specialist need is required. The company spends circa £100m annually on behalf of its clients, and has direct billing relationships with all hospitals and specially negotiated tariffs with private hospital groups and other providers.

“We have a large portfolio of clients who enjoy favourable hospital procurement costs and access to our Chief Medical Officer and second opinion services,” says Richard. “Where detailed case management is required, our nurse case managers can provide a full micromanagement service, ensuring that the appropriate medical care pathway is taken, without any delays in authorisation and without any hospital restrictions if required. We can also develop bespoke provider networks to make optimal use of our clients’ procurement spend.

“We have the flexibility to provide a bespoke service according to each client’s requirements from providing access to our UK hospital network through to full case management and everything inbetween. We also have our own in-house systems and technology, which means we have the ability to accommodate varying requests specific to clients’ requirements.”

Facilitating UK healthcare International insurers find the service from Healix Health Services highly effective in managing claims for medical treatment in the UK on their behalf. It is also of value to international employers

globalopportunityhealthcare.com

Issue 01

| Global Opportunity Healthcare Private Patients 2016

65

Healix Health Services

|

who have expatriate employees working and living in the UK with their families. Some international governments, such as those in the Middle East, also find the service attractive where they are unable to provide an extensive health service within their own countries.

“Some employers don’t have healthcare schemes of their own, instead opting to approach insurance companies to cover their employees’ healthcare needs. An insured member will have treatment whilst in the UK under the terms of their insurance with the bill funded by the insurer. Healix will provide the medical claims administration, ensuring the patient is looked after and receives appropriate treatment and that costs are controlled.” says Richard.

“Expatriate employees based in the UK requiring medical treatment, or with specialist healthcare needs, don’t have access to the NHS in the same way as UK residents so Healix will administer their medical needs on behalf of their employer. We can cover the full range of medical needs which a patient may have, from a simple cough or GP services to a hip replacement for example, as well as some complex heart and cancer conditions requiring treatment in the UK.” Some international companies may decide to self-

fund treatment for their employees in the UK. “We would provide a medical helpline to those members and they would call us if there was any medical treatment required. We would then take them through a medically-based assessment so they can get access to the best medical treatment.”

Generally, most patients are already in the UK as expatriates or travellers, but Healix can also manage cases on behalf of clients for patients travelling to the UK specifically for treatment that may not be available in their home country. In these cases Healix can provide additional medical support for medical escorts to accompany the patient travelling to the UK and home again if required. Healix can also supply additional supportive services such as aftercare nursing, cashless pharmacy services and 24 hour medical helplines.

“Whilst some companies do medically assess their employees before transferring them abroad, there may be issues of pre-existing medical conditions that mean that some are at a higher risk of needing unplanned hospital treatment whilst abroad. To make allowances for this risk, we can assist with pre-medical screening and arrange that on behalf of employers and insurers.

IMAGES: WWW.SHUTTERSTOCK.COM

66

Global Opportunity Healthcare Private Patients 2016

| Issue 01

globalopportunityhealthcare.com

|

Healix Health Services

HEALIX CASE MANAGEMENT In summary, our case management team will: lM anage a medical claim from first appointment to discharge l Gain

appropriate and relevant medical information relating to the claimant’s treatment so that their claim can be pre-authorised l Assist

and advise on available treatments and care pathways l Make appointments and referrals as required l Discuss

treatment plans with the treating medical and multi-disciplinary team and monitor all planned and delivered care to ensure that this remains routine and customary and in line with the patient’s insurance policy/scheme benefits l Answer

queries from the patient and provide an explanation for treatment plans and drug therapies proposed l Organise/source a second opinion if required.

Bespoke case management Requiring serious medical treatment is a challenging experience for any patient. It can become more demanding when living or working outside your home country and struggling with potential language barriers or general concerns about receiving care in a foreign environment.

“We can provide full medical case management for any treatment,” says Richard. “Advising a patient on where they are going for treatment, holding their hand throughout, and providing a fully-managed care pathway for the entirety of their care. If a patient requires physiotherapy treatment, for example, we can prearrange that so they know that care is already waiting for them.”

And with the highest ratio of medically qualified to administrative staff in the UK managed health services industry, every client can be assured of a superior quality of service in the medical case management they receive. “Many of our staff managing cases are qualified nurses who act as named case managers - they liaise with the patient and provide crucial reassurance and advice throughout the entirety of treatment.”

It is the bespoke nature of care that has proved

‘We have the flexibility to provide a bespoke service according to each client’s requirements - from providing access to our UK hospital network through to full case management and everything in-between.’

critical to Healix’s success, particularly when conventional health insurance companies are often only able to offer a ‘one size fits all’ care package.

Healix ensures that no aspect of care is overlooked with their ‘end to end‘ case management solution ensuring the highest standards of comprehensive care, from first appointment to discharge.

Saunders explains; “Healix case managers handle all cases, from taking that first initial call from a patient to settlement of the final invoice. They check that treatment is covered; arrange and manage treatment with appropriate hospitals, specialists and other providers; authorise bills for payment and settle them in sterling on behalf of our clients.”

“Our favourable tariffs are also passed onto our clients, meaning they’re getting a big saving as opposed to going direct. For example, clients may get a 30 per cent reduction in their medical bills as a result of using the Healix network. Although a portion of this will be used to pay for Healix’s services, clients still achieve a significant saving straight to the bottom line.”

And with many specialist treatment centres based in the UK, international buyers often look to the UK when complex treatments are required.

Healix’s bespoke service combined with their extensive expertise in the field of medical and risk management allows them to deliver cost-efficient solutions to such clients, without compromising on continuous high quality.

So it comes as no surprise that Healix Health Services has won the ‘Best Healthcare Trust Provider Award’ in the prestigious annual Health Insurance Awards five times over the last six years, as well as accreditation from both the International Organisation for Standardisation and ‘Best Companies’.

Further information www.healix.com

globalopportunityhealthcare.com

Issue 01

| Global Opportunity Healthcare Private Patients 2016

67

Great Ormond Street Hospital

|

A unique combination of cutting edge experimental research and treatments from multidisciplinary teams of paediatric specialists cements Great Ormond Street Hospital as an international beacon for world leading paediatric care, says Trevor Clarke, Director of the International and Private Patients Service at GOSH

Leading the way in international paediatric care

G

reat Ormond Street Hospital for Children (GOSH) in central London is an international centre of excellence and is recognised as one of the few world-class specialist hospitals for children. With over 300 consultants and more than 50 paediatric specialties under one roof, GOSH is uniquely able to diagnose and pioneer treatments for children – especially for those with highly complex, rare or multiple conditions.

“This is close to unique, certainly in Europe and more broadly globally,” says Trevor Clarke, Director of the International Private Patients Service at Great Ormond Street. “Any child with multiple problems can be referred and dealt with under one roof – this is particularly important for children born with congenital problems.”

The hospital’s mission since its founding in 1852 (originally founded as the Hospital for Sick Children) is simple – to deliver world-class, high-quality clinical care for children from all across the globe.

This is no better embodied than in the GOSH motto, ‘The child first and always.’ The facility is now rated as one of the top four children’s research hospitals in the world. “Our ability to deal with a multitude of serious diseases has fuelled our reputation, alongside our partnership with the UCL GOS Institute for Child Health,” says Trevor.

As one of the UK’s leading academic and research powerhouses, University College London (UCL) joined forces with GOSH in 1946 to form the UCL Great Ormond Street Institute of Child Health

68

Global Opportunity Healthcare Private Patients 2016

| Issue 01

– now the largest concentration of children’s health research in Europe.

This research at GOSH keeps all their complex and specialist care cutting edge – the hospital now has the largest epilepsy surgery centre in Europe, the biggest centre in the UK for children needing brain surgery and one of the two most comprehensive centres in Europe for paediatric bone marrow transplantation (BMT).

World leading MDT care

Many of the children treated at GOSH require expert care from a range of specialists. With a total focus on high level paediatric care, the hospital only employs specialist clinicians trained specifically in the care of children.

“Our multidisciplinary teams (MDTs) are all clinical professionals who have come through the paediatric training route. Our focus always remains on the contribution of all our individual professions to the

TREVOR CLARKE Trevor Clarke has been working in healthcare management for the past 25 years in the UK. He has undertaken a number of senior roles in Operational Management, Strategic Development and was Chief Operating Officer/Deputy Chief Executive at Great Ormond Street Hospital for Children. Lately he has taken the role of Director of International Services and has responsibility for the delivery of treatment services for international and private patients in London and the strategic development of education, training and consultancy services overseas.

globalopportunityhealthcare.com

|

Great Ormond Street Hospital

Eid celebrations at GOSH

globalopportunityhealthcare.com

Issue 01

| Global Opportunity Healthcare Private Patients 2016

69

Great Ormond Street Hospital

| management of the child. So the GOSH culture is very much not a doctor-led service – all are valued as part of the entire team.”

From a learning standpoint, GOSH welcomes overseas clinicians from all over the world to sit through some of their MDTs. “It really is a unique opportunity,” says Trevor. And with more than 20 per cent of its staff coming from overseas, the hospital continues to attract the best medical talent – from international consultants to nurses and clinical support staff. “We have over 3000 staff with 600 recruited from Europe and beyond. That’s an incredible number.”

State-of-the-art equipment using the latest technologies also enables quicker and more accurate diagnoses. They include a radiology suite with cutting-edge diagnostic imaging equipment, one of the most advanced operating theatres in the world, with the latest surgical equipment fully integrated within the walls and ceilings, the only dedicated 24 hour paediatric interventional radiology service in the UK and an extensive on-site laboratory service.

Above: GOSH has the widest range of health services for children on one site in the UK Right: GOSH treats over 5,000 children from over 80 different countries each year

pathology, genetics, haematology, histopathology, immunology, microbiology, virology and a paediatric malignancy unit, meaning treatment can start much earlier with a faster recovery time.

“The fact that a child is here means they have a higher potential to be selected to begin potentially life-saving newer treatments” says Trevor.

Ground breaking research

The International & Private Patients Division

Research and innovation is the cornerstone of any battle to fight disease, and has been one of GOSH’s three main ambitions since its inception. “A government minister once said, ‘if you don’t have a place like GOSH, you would have to invent one,’” notes Trevor.

“The GOSH biomedical research centre supports experimental medical research enabling scientific discoveries made in laboratories to be translated into first in child clinical studies and is very much focused on cellular and gene therapies,” he explains.

“This research is something that the UK needs, and at GOSH we are committed to translating this into the latest treatments.”

On-site extensive lab services include chemical

In 2015 GOSH received referrals from 88 countries, treating over 5,000 children – a testament to the global presence of GOSH for world leading specialist paediatric care. The International and Private Patients Division (IPP) now has 53 dedicated inpatient beds in London, with a dedicated Gulf Office in Dubai, ensuring all international patients receive tailored referral and treatment plans from a dedicated, multi-lingual support team.

“To support our international patients and their families, we provide 24/7 telephone support in all languages, in addition to our on-site team of 11 Arabic interpreters,” says Trevor. “Staff can also help with transfers to the airport, finding accommodation and so on.”

When dealing with children suffering with very

70

Global Opportunity Healthcare Private Patients 2016

| Issue 01

globalopportunityhealthcare.com

|

Great Ormond Street Hospital DEDICATED GULF OFFICE The Gulf office provides a range of support both before and after a patient is treated at GOSH. This includes: l Arranging appointments, investigations and admissions. l Advising on any special requirements that need to be followed before investigations or treatment and answering any queries related to treatment. l Advising on length of stay and estimate of cost. l Supplying information on local hotel accommodation and travel to the hospital. l Providing information and letters of support to facilitate travel visas for the UK.

Further information

To get in touch with the Gulf office contact gulfoffice@gosh.nhs.uk.

can do this at their bedside if they can’t move, although we do have a separate school facility on-site.”

A 5-star service

‘The GOSH biomedical research centre supports experimental medical research enabling scientific discoveries made in laboratories to be translated into first in child clinical studies and is very much focused on cellular and gene therapies.’ serious health problems like cancer or brain tumours, it’s not a question of waiting for school holidays to seek expert treatment at GOSH. “Because our work is complex, ill children need to come whenever they’re sick,” Trevor explains.

“But if a child is able, their education is maintained during their time with us.”

“We have a hospital school that will liaise with a patient’s local school. Our teachers can then learn the lesson plans and re-teach it to the child. They

globalopportunityhealthcare.com

GOSH places great emphasis on the support and care provided for children and their families by nurturing an open and supportive atmosphere, ensuring that parents and patients are wellinformed and closely involved throughout the treatment process. Children and families are always treated with respect, trust, concern and openness.

GOSH also works with luxury hospitality consultants in London, meaning staff in IPP are highly trained in customer service, hospitality, housekeeping and food and drink services.

“This is an exciting time for IPP,” Trevor says.

“We’ve recently increased our capacity with ten extra beds, as well as developing a programme to enhance the patient experience and are trialling new services including a hospitality team and an inroom catering menu. All of our new rooms include an en-suite bathroom and a parent bed. As such, most parents will stay with the child. But we can help source local accommodation if another parent is here often or if there are other family members visiting,” he explains. “We’re looking to further develop our services for international and private patients with the next couple of years proving an exciting start to these developments.”

Further information Great Ormond Street Hospital for Children International and Private Patients Service The Harris International Patients Centre The Octav Botnar Wing Great Ormond Street London, WC1N 3JH Tel: +44 (0)20 7762 6822 privateinfo@gosh.nhs.uk www.gosh.com.kw|www.gosh.ae

Issue 01

| Global Opportunity Healthcare Private Patients 2016

71

Guy’s and St Thomas’ Private Healthcare

|

Clinical excellence and world-class patient care Guy’s and St Thomas’ Private Healthcare offers a unique combination of world-class clinical services delivered by internationally recognised clinicians. Both UK and overseas private patients benefit from the highest standards of care from one of the largest and safest NHS Trusts in the UK, says Dr Ian Abbs, Chief Medical Officer for Guy’s and St Thomas’ NHS Foundation Trust

Guy’s Tower beside The Shard

|

Guy’s and St Thomas’ Private Healthcare

G

uy’s and St Thomas’ NHS Foundation Trust is a world-class organisation with a proud history stretching back more than 900 years. We are a centre of excellence for clinical services, education and research. Our clinical services are delivered from two of London’s best known teaching hospitals, Guy’s Hospital and St Thomas’ Hospital. Evelina London Children’s Hospital on the St Thomas’ site has a growing reputation as a centre of excellence for the delivery of paediatric care.

As one of the largest, most clinically comprehensive and high quality hospital trusts in the United Kingdom, we constantly strive to push the boundaries of the clinical care we offer in a safe and high quality environment which offers an outstanding patient experience. In recognition of our commitment to providing a high level of care for patients, Guy’s and St Thomas’ won the Quality of Care Award at the 2016 CHKS Top Hospitals Awards.

Our history of innovation includes: l Conducting the first blood transfusion in 1818 l Tissue typing was invented at Guy’s in 1937 lF irst artificial intraocular lens implantation after cataract surgery in 1949

globalopportunityhealthcare.com

Issue 01

| Global Opportunity Healthcare Private Patients 2016

73

Guy’s and St Thomas’ Private Healthcare

|

services, with the privacy, comfort and discretion of a private facility located in the heart of London.

We treat adult patients in our dedicated outpatient and inpatient facilities, giving access to more than 60 clinical services and sub-specialties, with 280 consultants practising privately who are part of the wider Guy’s and St Thomas’ NHS Foundation Trust. Private patient clinical services include specialties such as Cardiovascular, Cardiac Surgery, Dermatology, Obstetrics and Gynaecology, Assisted Conception, Paediatrics, Renal (kidney) Transplantation and Urology.

‘We are one of the only services in the UK trialling new models for acute heart failure and we are the only cardiology service in the UK using parachute implants, a method which isolates the damaged muscle to enhance pumping efficiency.’

C onducting the first kidney transplant in South Thames in 1967 lF irst European public hospital to use da Vinci robots to treat skin cancer in 2001 lP ioneering live kidney transplants in the UK using robots in 2005 lB ecoming the first Robotic Surgery Institute in the UK in 2014.

We are part of King’s Health Partners, one of only eight academic health sciences centres in the UK and 66 worldwide. This partnership with a world-class university, King’s College London, brings together world-class research, clinicians with international reputations, education and clinical practice for the benefit of patients.

With the ability to access the full support of a top NHS teaching facility, Private Patient Services at Guy’s and St Thomas’ are able to offer a comprehensive range of clinical specialties for UK and international patients. With world-renowned consultants, leading edge technology and modern facilities, we provide an unrivalled breadth and depth of experience across a wide range of clinical services. Our private patients benefit from a unique combination of high quality specialist medical

Clinical excellence Many of our clinical services are internationally recognised as centres of excellence. Our consultants are leaders in their field, hold senior teaching positions at top universities, and are active in research and clinical trials. This combination of clinical expertise, research and academic knowledge ensures that our long tradition of undertaking groundbreaking research and engagement with partners continues to drive forward innovations that benefit patients. Our reputation for world-class care is showcased by the following services:

l

74

Global Opportunity Healthcare Private Patients 2016

| Issue 01

Cardiovascular services

Below left: Evelina London Children’s Hospital Below right: St Thomas’ opposite Big Ben

Our highly acclaimed cardiovascular service is one of the largest in the UK and offers a range of services including adult congenital heart disease, arrhythmia, heart failure, inherited cardiac conditions, interventional cardiology, structural intervention and valve disease. We are one of the only services in the UK trialling new models for acute heart failure and we are the only cardiology service in the UK using parachute implants, a method which isolates the damaged muscle to enhance pumping efficiency. We have one of the largest structural interventional cardiology services within the UK and we are one of the leading centres in the world for transcatheter valve therapies, having performed the world’s first three transcatheter mitral valve replacements in 2014.

globalopportunityhealthcare.com/private patients

|

Renal service and transplantation We have been leaders in kidney care since our renal service was established in the 1970s. Our expertise in kidney transplantation is recognised worldwide; we operate the largest renal transplant programme in Europe and one of the largest paediatric transplant programmes in the world. We specialise in adult and paediatric complex cases and are renowned for providing transplants for many patients for whom usually, transplantation would be impossible. We are one of the only services in the UK to offer a blood group incompatibility programme which has a success rate of 95 per cent and has been expanded to paediatric transplantation.

We were the first centre in the UK to have a living donor transplant programme and are home to the largest and most active living kidney donation programme in the UK. Guy’s and St Thomas’ pioneered the use of robotic technology in the UK and our consultant transplant surgeons pioneered the world’s first use of 3D printing to support the successful transplantation of an adult donor kidney into a child in 2015. Our renal team is the first in the UK and the second in Europe to use new robotic technology to undertake full kidney transplants which involves using an advanced da Vinci robot to perform keyhole surgery to implant donor kidneys in patients.

Assisted Conception Unit Established in 1991, the Assisted Conception Unit at Guy’s Hospital has developed a reputation for excellence in both NHS and private infertility

globalopportunityhealthcare.com

Guy’s and St Thomas’ Private Healthcare

treatment. We are the largest and most successful clinic in the UK for Pre-implantation Genetic Disorders (PGD) and licensed to carry out stem cell research. We have a team of fertility specialists that include consultants, embryologists, scientists, nurses and counsellors who are all dedicated to delivering the best personalised care to all patients.

Our dedication to pioneering research and innovative techniques has helped us to achieve above average success rates for both our NHS and private patients.

Maternity services The Lansdell Maternity Suite has been offering private maternity care for more than 20 years and boasts some of the most accomplished and well trained obstetricians, neonatologists, anaesthetists and midwives. Women deliver their babies in a delivery suite accredited to the highest standards of safety available, should the need arise. They have the reassurance of knowing that they have access to the hospitals’ full neonatal intensive care services.

Evelina London Children’s Hospital Evelina London is the second largest provider of acute children’s services in London, and was the first new children’s hospital in London for more than 100 years when the new building on the St Thomas’ site opened in 2005. Our achievements include carrying out the world’s first MRI-guided children’s heart valve procedure and performing 1 in 5 of the UK’s kidney transplants for paediatrics.

The purpose-built facility offers a modern state-

Issue 01

| Global Opportunity Healthcare Private Patients 2016

75

Guy’s and St Thomas’ Private Healthcare

|

Guy’s and St Thomas’ Private Healthcare

|

‘Guy’s and St Thomas’ is proud of our reputation for world-class care and outstanding clinical excellence which enables us to offer the best quality care for patients from all over the world.’ of-the-art design catering specifically for the needs of children and their families. Evelina London has an international reputation for paediatric health, offering services from antenatal diagnosis through to childhood, adolescence and into adult life with particular emphasis on nephrology, neurology, cardiology and intensive care.

Exceptional patient care Private patients choose to have their treatment at Guy’s and St Thomas’ as they not only benefit from the expertise of consultant-led care for a range of complex procedures and medical treatments but they also have the reassurance of being treated in one of the top teaching hospitals in the country.

We have dedicated facilities for our private patients. Outpatients are seen at Westminster Bridge Consulting Rooms and inpatients are cared for on two dedicated private inpatient wards which make up the Westminster Unit. Patients benefit from the privacy and comfort of private ensuite rooms

76

Global Opportunity Healthcare Private Patients 2016

| Issue 01

which offer outstanding views over the river Thames, and an unrivalled panorama that stretches across London to many of the city’s famous landmarks including Big Ben and the Houses of Parliament.

We welcome patients from the UK and overseas and are proud to offer facilities that suit patients of different nationalities and faiths. Our aim is to ensure that the cultural needs of all patients are met with sensitivity and understanding. This includes catering for international and clinical dietary requirements, providing language support and interpretation services.

International referrers, embassies and government bodies We work with many of the world’s leading private medical insurance companies, embassies and third party referrers. Our aim is to work in partnership to provide a seamless process for international patients from initial enquiry to treatment and recovery, so that patients experience high standards of care throughout their stay with us.

Guy’s and St Thomas’ is proud of our reputation for world-class care and outstanding clinical excellence which enables us to offer the best quality care for patients from all over the world.

Patients are at the heart of everything we do and we pride ourselves on ensuring the best possible patient experience as well as safe, high quality care.

Further information Tel: +44 (0)20 7188 5197 Email: privatepatientenquiries@gstt.nhs.uk www.guysandstthomasprivatehealthcare.co.uk

globalopportunityhealthcare.com

Guy’s and St Thomas’ Private Healthcare

|

Building a fresh start The Centre for Pre-implantation and Genetic Diagnosis (PGD) at Guy’s Hospital has long established itself as a world leader in fertility treatment and genetic diagnoses and is the biggest programme in Europe as Mr Yacoub Khalaf, Director of the PGD programme at Guy’s and St Thomas’ NHS Foundation Trust, tells Jack Ball

S

ituated on the 11th floor at Guy’s Hospital near London Bridge, the PGD unit is somewhat of a haven – artwork lines the walls with a palpable air of positivity and calm. Since 1997, the unit has grown to become one of the largest assisted conception units and centres for pre-implantation and diagnosis in the UK.

In terms of pre-implantation and genetic diagnosis as an IVF (in vitro fertilisation) technique, the unit is a national leader, attracting patients from across the globe who seek help in producing happy and healthy children – free of serious illnesses passed down through the generations.

“What is so excellent about the PGD service at Guy’s and St Thomas’ is that it is done the right way,” says Mr Yacoub Khalaf, Director of the PGD Programme at Guy’s and Thomas’ NHS Foundation Trust. “We have a process whereby the referral is received, we make sure the diagnosis is correct and we counsel each patient fully on the different options available to them.

“We always treat people in the most productive way. We structure their IVF in a way that means we only test embryos of a good quality to help make a healthy baby.”

PGD as an option

The pre-implantation genetic diagnosis at Guy’s Hospital is specifically available to patients who are at risk of having a child with serious genetic or chromosome disorders – such as cystic fibrosis, spinal muscular atrophy, muscular dystrophy and haemophilia.

While the media may fuel thoughts of ‘designer babies’ through fertility processes like PGD and IVF treatments, the reality is far different. “We perform targeted testing for diseases that a patient is already aware of,” Yacoub explains. “We don’t do anything by chance – everything is done by an approved process.”

The unit cultures embryos to day five of development, where more than one cell is produced – offering more cells containing material which is available for testing. “We have the technology to magnify or amplify this amount of DNA to become significant,” says Yacoub.

PGD is one of two options traditionally available to these high-risk patients. Testing during pregnancy

78

Global Opportunity Healthcare Private Patients 2016

| Issue 01

globalopportunityhealthcare.com

|

Guy’s and St Thomas’ Private Healthcare

IMAGE: WWW.SHUTTERSTOCK.COM

only leaves one avenue available to prospective parents - if a genetic abnormality is found then the option of termination is available to them. “This is why PGD as a second option is much more appealing to avoid making this difficult decision,” says Yacoub.

A unique offering

The wealth of clinical expertise already on hand at Guy’s, as part of one of the UK’s leading NHS Foundation Trusts, also ensures the best possible outcomes for every patient treated at the unit.

“Every Thursday morning there is a multidisciplinary meeting to discuss each case at the unit.

We make sure there is a genetic input, a scientist’s input, a lab input and a clinical input – this is why we have maintained our position over the years as the most successful PGD unit in the country.”

MR YACOUB KHALAF Mr Yacoub Khalaf qualified in Egypt 1984 (Assiut University) and completed his MD in Birmingham (UK) in 1994. Following research posts in Birmingham and London, he became a Lecturer in the Department of Obstetrics and Gynaecology in 1996, subspecialty Fellow in Reproductive Medicine and Surgery in 1998 and was appointed Consultant in Gynaecology and Reproductive Medicine in 2001 at Guy’s and St Thomas’ NHS Foundation Trust. In 2003 he was appointed as an Honorary Senior Lecturer in Reproductive Medicine and Surgery at King’s College London.

In 2004, Yacoub was appointed as Medical Director and HFEA Person Responsible for the Assisted Conception Unit (ACU) at Guy’s and St Thomas’, a post that he holds to date. Over the past 15 years, he has been making a significant contribution to the development of the ACU as a leading centre for Assisted Reproduction, Pre-implantation Genetic Diagnosis and Stem Cell research. He is an advisor to the Human Fertilisation and Embryology Authority (HFEA), a member of HFEA Licensed Centres.

globalopportunityhealthcare.com

Increasing access The unit’s notable success means referrals come from all corners of the globe – from Norway and Nigeria to Qatar, Kuwait, the UAE and Saudi Arabia. The prevalence of different consanguineous diseases ranges between communities such as these. While sickle cell anaemia is more prevalent in the Middle East, the Jewish community sees more metabolic disorders like Tay Sachs disease or Gaucher’s disease – all of which can be identified at the unit.

The list of tested diseases at the unit grows by the day – helped in no small part by all testing and implantation facilities being on-site. “Other fertility centres perform IVF, gather and test the embryos and send them to another centre off-site,” says Yacoub. “At Guy’s ACU the biopsy goes to our molecular lab which is just down the corridor. I don’t believe any other centre in the country does everything in-house.”

“We have one of the largest teams in the UK, including genetic counsellors, clinical geneticists, molecular geneticists and assisted conception specialists,” says Khalaf.

In 2013, the unit completed 1,500 cycles. And in 2016 this figure has almost doubled. With a team of 85 highly qualified specialists, performing a sevenday service, testing embryos every day of the week, the PGD programme at Guy’s is a leader in its field.

Yacoub believes this unique capability truly sets the unit apart. “Their distinction, dedication, and firm commitment to comprehensive and multi-disciplinary care are frankly second to none.”

Further information Tel: +44(0)20 7188 2300 Email: ivf.info@gstt.nhs.uk www.guysandstthomasprivatehealthcare.co.uk

Issue 01

| Global Opportunity Healthcare Private Patients 2016

79

Guy’s and St Thomas’ Private Healthcare

|

A beating heart of clinical excellence The cardiovascular unit at St Thomas’ Hospital has built a truly international reputation, increasing access for patients from across the globe who may have traditionally been denied access to more conventional heart procedures, as Professor Simon Redwood, Consultant Cardiologist based at Guy’s and St Thomas’ NHS Foundation Trust, tells Jack Ball 80

Global Opportunity Healthcare Private Patients 2016

| Issue 01

T

he cardiovascular directorate at Guy’s and St Thomas’ NHS Foundation Trust is somewhat of a powerhouse in terms of its internationally renowned cardiology treatments. It combines three inter-related services – cardiology, cardiac surgery and vascular surgery on the St Thomas’ Hospital site, home to its inpatient and day case wards, theatres and cardiac catheter labs, the majority of outpatient facilities and noninvasive investigative units. Housing a number of expert cardiac sub-specialties, the department has built up a formidable international reputation – with multi-disciplinary teams of expert nurses, consultants and researchers using the latest clinical equipment – innovating ground-breaking clinical advancements to ensure the very best in comprehensive cardiac care.

“I’ve always felt a lot more comfortable bringing my private patients here, partly because of the catheterisation laboratory facilities and the range of equipment we have, but also because the nursing

globalopportunityhealthcare.com

|

Guy’s and St Thomas’ Private Healthcare PROFESSOR SIMON REDWOOD Professor Simon Redwood is professor of interventional cardiology and honorary consultant cardiologist and director of the cardiac catheter laboratories at Guy’s and St Thomas’ NHS Foundation Trust.

He is Immediate Past President of the British Cardiovascular Intervention Society and a recognised Fellow of the American College of Cardiology (FACC), Royal College of Physicians (FRCP) and Society for Cardiovascular Angiography and Interventions (FSCAI).

Simon has been performing percutaneous coronary intervention for over 20 years. He also runs an active research team, has raised over £10 million in grant funding and has supervised over 14 MD and PhD theses.

IMAGE: WWW.SHUTTERSTOCK.COM

care on the ward is excellent,” says Professor Simon Redwood, lead interventional consultant at St Thomas’ Hospital.

All private cardiac patients are housed in the Westminster Unit at St Thomas’ Hospital – situated on the 12th Floor of the hospital’s North Wing. All rooms have en suite facilities, nurse call system, direct dial telephone and televisions, with most rooms boasting views of the Thames and the Houses of Parliament that rival some of the capital’s most luxurious hotels.

TAVI

Traditional heart valve surgery is normally the most effective way to treat valve stenosis (narrowing of the heart valves) or a leaky valve (where the valve does not close properly and blood leaks backwards).

However, there are risk factors that could prevent a patient from undergoing these more conventional heart procedures – including age (older patients

globalopportunityhealthcare.com

are more at risk of complications during and after surgery), those suffering from diabetes or other vascular diseases, renal impairment, lung disease, previous strokes, or other diseases traditionally associated with older people.

“TAVI (transcatheter aortic valve implantation) is a minimally invasive way of treating the valve,” Professor Redwood explains. “A valve has been developed on a scaffold support, allowing us to squash it down. So rather than being an inch in diameter, the device is about six millimetres. We then introduce it through the artery at the top of the leg, bring it into position and inflate it with a balloon.”

TAVI’s non-invasive nature also means recovery time is greatly improved, reducing the amount of time spent in hospital – particularly important for patients visiting from overseas. “A conventional procedure would take up to three months for the breast bone to completely recover,” he says. “But I’ve seen patients sitting up in bed and having a meal after a TAVI procedure.”

The centre at St Thomas’ is now the largest in the country, having dealt with more than 700 cases of aortic valve replacement using TAVI technology – due in part to the Trust’s status as one of the largest cardiac surgical groupings in the country. “Because of this volume we have permanent catheter lab staff here who are very comfortable working with complex cases,” says Professor Redwood. “This is different to some private hospitals, with only elective procedures performed on a regular basis.

“We only tend to offer these treatments to patients over the age of 70. But we’re starting to move to lower risk patients as we receive more long-term data. In my opinion TAVI will be the dominant way we treat aortic stenosis in ten years’ time. It will be uncommon, if not unheard of, to have a conventional invasive operation.”

Issue 01

| Global Opportunity Healthcare Private Patients 2016

81

Guy’s and St Thomas’ Private Healthcare

|

Guy’s and St Thomas’ Private Healthcare

|

The ‘Parachute’

A centre of excellence

Building upon the Trust’s ground-breaking work in TAVI, Professor Redwood now has his sights set firmly on the next generation of cardiac treatments.

Named after its appearance, the ‘Parachute’ is a small device which measures 64-85mm in diameter. It is implanted in the main pumping chamber of the heart where there is damaged muscle preventing the heart from pumping blood around the body properly.

“When someone has had a significant heart attack and a large part of the heart ventricle has died, they develop heart failure,” he explains. “At this point they can get very short of breath and they become very limited in what they can do.

They may be unable to walk or need help doing so, possibly requiring a motorised vehicle to get around.”

Similarly to a TAVI procedure, the device is introduced from the top of the leg and fitted in the ventricle to reduce its size and allow it to co-ordinate, function and pump better. “In the cases we’ve performed there has been a dramatic improvement in patient symptoms,” says Professor Redwood. “And although it’s a very new procedure and we’re the only centre in the country doing it, the data we’ve gathered so far looks extremely promising.”

“The Parachute implant is an exciting new procedure to help people with severe heart failure,” adds Dr Ronak Rajani, fellow cardiologist and colleague of Professor Redwood. “These are patients who have received all other conventional treatments but are still significantly debilitated by their symptoms. It is bringing real benefits for our patients and we look forward to offering it to more people with severe heart failure.”

The cardiovascular unit at St Thomas’ Hospital is the only clinical service in the country undertaking Parachute procedures. And having already established itself as a clinical leader in TAVI, the unit is proud of its expertise in a range of services including adult congenital heart disease, arrhythmia, heart failure, inherited cardiac conditions, interventional cardiology, cardiac imaging, structural intervention and valve disease.

“Because of the volume of cases we see, we have an enormous amount of expertise when treating patients here,” says Professor Redwood. “We also have many multi-disciplinary teams (MDTs), and would never undertake a TAVI procedure without one. Our TAVI MDT includes an interventional cardiologist such as myself, cardiac surgeons, an echocardiographer who is specifically interested in the TAVI services, as well as a TAVI nurse case specialist whose job is to deal only with those patients.”

A testament to its international reputation, the unit now also runs case demonstrations of its TAVI procedures – performed in front of a live audience and streamed internationally. These demonstrations have grown exponentially, increasing from 150200 attendees seven years ago to the most recent demonstration attracting nearly 2,000 people.

“We are now on the map as one of the leading centres in world for performing transcatheter valve implants. We’re certainly in a group of three or four units that always gets asked to transmit. And we’re starting to get international referrals because of that.”

82

Global Opportunity Healthcare Private Patients 2016

| Issue 01

Further information Tel: +44 (0)20 7188 5197 Email: privatepatientenquiries@gstt.nhs.uk www.guysandstthomasprivatehealthcare.co.uk

globalopportunityhealthcare.com

Bupa Cromwell Hospital reflects its London location with an international flavour and exceptional care, Ahmed El Barkouki, Commercial Director tells Jack Ball

|

Bupa Cromwell Hospital

The full package

T

he UK and London in particular continues to enjoy a global reputation as a centre of healthcare excellence. International private healthcare patients are drawn to the capital’s cosmopolitan nature, its diverse population and the highest standards of clinical expertise within the private healthcare sector.

Bupa Cromwell Hospital is situated in the leafy residential area of South Kensington, West London.

Having recently undergone a multi-million pound redevelopment, the hospital continues to set the industry benchmark in private patient care, offering an array of world-leading consultants in a superior care environment including four new luxury suites.

The facility was built in 1981 before being acquired

84

Global Opportunity Healthcare Private Patients 2016

| Issue 01

by Bupa in 2008. Many of those treated at the hospital are attracted by the 500 or more consultants who stem from London’s top teaching hospitals and who are trained to the highest level in over 70 specialties, delivering exceptional clinical care through a unique multidisciplinary team approach (MDT).

“Bupa Cromwell reflects its London location. We are a melting pot of nationalities who work cohesively together to provide a unique offering,” says Ahmed El Barkouki, Commercial Director at the hospital.

This shared universal standard of expertise, a comprehensive approach to all aspects of care, and a world class newly-renovated modern facility keeps Bupa Cromwell one step ahead of the pack in terms of high level private care.

globalopportunityhealthcare.com

|

Bupa Cromwell Hospital

in that course of action,” says Ahmed. “We have roughly ten multidisciplinary teams and many of our consultants state that our hospital is advanced in multidisciplinary care compared to other private hospitals in London.” Due to the large amount of patient cases requiring discussion, the hospital’s lung MDT is so advanced that they meet every two weeks.

Industry benchmark With over 50 per cent of total patients coming from 144 different countries, the hospital is not content with simply providing an exceptional level of clinical care from consultants and support staff.

“Some may think that providing excellent medical care is sufficient. This is increasingly not the case,” says Ahmed. “Many aspects of patient care are non-medical, with the complete hospital experience benchmarked against every customer service experience that our patients may have. Whilst other countries perform well in the area of non-medical care, the UK has some catching up to do.”

As part of their effort to redress this, the hospital has redeveloped four of their superior care suitesthe Royal, Presidential, Ambassador and Executive.

AHMED EL BARKOUKI

Unique offerings The hospital is extremely strong in many specialities including orthopaedics, lung, liver, neurological and gastrointestinal care and is regarded as a centre of excellence for oncology, cardiology, paediatrics and complex surgical procedures. With a vast variety of specialisms housed under one roof, the hospital takes a unique approach to ensuring comprehensive patient care.

“Almost all of our major specialities have a multidisciplinary team (MDT) attached to them with the most complex patient cases discussed by a pathologist, a radiologist, a surgeon and a clinician.

This environment ensures a decision is not made by one person but a group of peers who partake

globalopportunityhealthcare.com

Ahmed El Barkouki’s career spans 16 years in the hospitality and healthcare industries. Before joining Bupa Cromwell Hospital as Commercial Director in 2014 he held senior sales and marketing roles in luxury hotels, including Four Seasons Hotel and resorts, and the Maybourne Hotel Group (Claridge’s, the Berkeley and Connaught). He joined The Savoy hotel as Director of International Sales for its reopening, before setting up his own company to consult companies globally on how to attract high net worth clients from the Middle East, East Europe and South America.

Ahmed’s move to the Cromwell came from a desire to bring exceptional service quality to the healthcare industry. He is passionate about culture change to deliver the best customer outcomes, and is obsessed with excellence in customer service.

Issue 01

| Global Opportunity Healthcare Private Patients 2016

85

Bupa Cromwell Hospital

|

Bupa Cromwell Hospital

|

Patients may range from international business leaders to heads of state with a wide range of services individualised to the requirements of each guest.

“There are separate amenities that come with the Royal and Presidential suites,” says Ahmed. “A patient is assigned a team of VIP coordinators similar to personal assistants for the duration of their stay as well as one to one nursing. A limousine service to pick up the patient from the airport is also provided along with medical evacuation from anywhere in the world, subject to an additional charge.”

Privacy for the most discerning of patients is also guaranteed with the redeveloped suites ensuring the upmost subtlety of care. The suites are in an isolated area on the fourth floor with separate entrances, an outside area for security details, large amounts of storage and a private nursing station that can be accessed externally without the need to enter the suite.

The new suites, as part of the wider redevelopment of the hospital, are one element of a broader effort to ensure the finest personal touch in private patient care, complementing the superior medical expertise historically associated with Bupa Cromwell Hospital.

Emotional wellbeing Equally important is the role of staff in maintaining the emotional wellbeing of an overseas patient who may be unfamiliar with the UK healthcare system.

The International Patient Centre at the hospital reflects a wider ability of London to cater to a

86

Global Opportunity Healthcare Private Patients 2016

| Issue 01

diverse variety of international cultures and tastes.

“The Centre offers free interpretation services to all of our international patients who do not speak English. We can provide a translation service for any language with frequent ones being Arabic, Greek, Russian and Chinese,” says Ahmed. The interpreters are integral in easing any apprehension that an international patient may have when commencing their treatment at Bupa Cromwell. “Some have been with us for more than 15 years, so they are very experienced and patients and consultants both value them greatly.”

Once a procedure is carried out, a patient’s stay at the hospital varies according to their condition or treatment required. “A patient will meet the consultant and when a procedure is scheduled, their stay can vary from two or three days to three to four months,” says Ahmed.

If a patient is no longer required to remain in hospital, the staff will help them find accommodation in the local area should they need further follow up care. “We have commercial arrangements with some of central London’s most luxurious hotels, as well as furnished apartments in the local area.”

Bringing together these crucial non-medical aspects of care and a unique multidisciplinary approach positions Bupa Cromwell Hospital at the forefront of private patient care, ensuring the hospital competes on a global stage.

Further information www.bupacromwellhospital.com

globalopportunityhealthcare.com

Edgbaston Medical Quarter in Birmingham is emulating Harley Street with its combined medical and healthcare facilities, says Mark Lee, Chief Executive Calthorpe Estates

|

Edgbaston Medical Quarter

Discover a community of medical excellence

Leafy Edgbaston with green open spaces, combined with period and modern medical properties, which give EMQ a distinctive character

88

Global Opportunity Healthcare Private Patients 2016

| Issue 01

globalopportunityhealthcare.com

|

Edgbaston Medical Quarter Leading clinics and worldclass treatment centres

MARK LEE Mark Lee is Chief Executive of Calthorpe Estates having taken up the role in 2012, after joining the business as Chief Financial Officer in 2008. Mark heads up the management team responsible for running the 640 hectare (1,600 acre) Edgbaston Estate, close to the centre of Birmingham, and various other UK property interests. The team focuses on custodianship, sustainable development and creating thriving communities. It is in charge of a multi-million pound regeneration portfolio including medical, office, residential, leisure and retail developments.

E

dgbaston Medical Quarter (EMQ) is at the centre of the medical and healthcare growth which is taking place in the West Midlands, in the heart of the UK. Based in Birmingham, and just 90 minutes from London by train with direct international flights to all major global destinations, Edgbaston is home to over 180 medical organisations, 80 hospitals and specialist care centres, 44 GP clinics and routine care facilities and 23 training facilities.

Calthorpe Estates manages the prestigious 640 hectare (1,600 acre) estate in Edgbaston, just a mile from Birmingham centre centre. Family-owned, it is one of the UK’s most forward thinking and progressive property investment and development companies. For 300 years it has been place-making and creating thriving communities within its Estate, to create the best places to live and work.

With its rapidly expanding medical and healthcare community, supported by internationally renowned training and educational facilities that sit alongside a vibrant leisure and lifestyle destination, it is easy to see why EMQ is becoming the ‘go to’ centre for medical treatment, cutting-edge healthcare and clinical trials.

As a centre of medical excellence it draws highly qualified and experienced clinicians, and offers some of the best places to be treated in the UK. Many of the clinics, and clinicians, are located in both London and Edgbaston; however EMQ can provide faster access to treatments, as well as delivering care without the premium price of London and without comprising on the quality of treatment, medical accommodation and leisure facilities.

Specialist care centres include oncology, trauma,

globalopportunityhealthcare.com

Issue 01

| Global Opportunity Healthcare Private Patients 2016

89

Edgbaston Medical Quarter

Award-winning places to eat including Simpsons Michelin starred restaurant

|

Edgbaston Medical Quarter

|

mental health, diabetes, addiction, eating disorders and fertility. It was in fact the specialist trauma centre at the Queen Elizabeth Hospital Birmingham, where the Nobel Peace Prize winner Malala Yousafzai was treated in the UK. The treatment she received was not only instrumental in Malala’s recovery, but Edgbaston and Birmingham also became her home.

It is also home to Cure Leukaemia and the Centre for Clinical Haematology, which are at the forefront of developing pioneering drug treatments and personalised medicine.

EMQ is home to a wide range of additional medical specialisms, including dentistry, osteopathy, plastic surgery, aesthetics, orthopaedics, ophthalmics and physiotherapy. Many of the clinics are within walking distance of one another and are located in attractive period buildings coupled with the privacy and convenience of on-site car parking.

The clinics sit alongside a powerful cluster of advanced research centres, healthcare institutions and academic centres. EMQ boasts the state-of-theart Queen Elizabeth Hospital Birmingham, the new Birmingham Dental Hospital and School of Dentistry, The Institute of Translational Medicine, The BioHub Birmingham, The Accelerated Trials Programme, as well the Rare Diseases and Personalised Medicine Centre which is helping to improve the diagnosis, clinical management and treatment of rare disorders.

Set within tree lined avenues with green open spaces within the Calthorpe Estate, the healthcare and medical facilities sit alongside a thriving leisure, lifestyle and commercial community. The area is home to Edgbaston Village, with its award-winning places to eat including Michelin-starred Simpsons

90

Global Opportunity Healthcare Private Patients 2016

| Issue 01

Edgbaston Medical Quarter is a centre for medical and healthcare excellence, it draws in highly qualified and experienced clinicians, and offers some of the best places to be treated in the UK. It boasts over 180 medical organisations, 80 hospitals and specialist care centres, 44 GP clinics and routine care facilities, and 23 training facilities.

restaurant, in addition to a growing choice of places to shop and relax. The niche retail and leisure businesses create a vibrant atmosphere that continues throughout the day, evening and weekend.

Birmingham has five additional Michelin-starred restaurants and is one of the UK’s top retail locations. It boasts Grand Central, The Bullring and The Mailbox, and is located just over a one hours drive away from Bicester Village. It is also home to a wide range of arts, cultural, leisure and sports facilities including Edgbaston Cricket Stadium, Edgbaston Golf Club, Botanical Gardens, The Hippodrome theatre and Symphony Hall. For those that wish to venture further afield, Shakespeare’s Stratford-upon-Avon is within a 45-minute drive.

The average hotel room rate for a four star hotel is over 40 per cent lower than London, for those that need to stay longer there is a wide range of accommodation options, ranging from serviced apartments and homes to let through to hotel suites with a concierge service and award-winning boutique hotels. Edgbaston is home to over 31 educational establishments, offering best-in-class teaching from nursery age through to higher education; they include the internationally renowned King Edward’s School and University of Birmingham.

The city is also home to green open spaces and over six million trees, one million of which can be found in Edgbaston. In total, Birmingham is a very friendly city that is closely connected, making it easy to get to and navigate around.

Further information www.calthorpe.co.uk/emqmt

globalopportunityhealthcare.com

|

Imperial Private Healthcare Imperial Private Healthcare

Clockwise, from right: Hammersmith Hospital; Queen Charlotte’s and Chelsea Hospital; Charing Cross; St Mary’s Paddington

|

Academic health With more than 9,000 patients treated every year, Imperial Private Healthcare, part of Imperial College Healthcare NHS Trust, is one of the largest private healthcare facilities in London. Located within five major teaching hospitals across north west London, and within easy reach of London’s Heathrow Airport, it has unparalleled access to London’s top consultants across all specialities.

With its academic partner, Imperial College London, it is one of the UK’s seven academic health science centres, working to ensure the rapid translation of research for better patient care and excellence in education.

Its hospitals are world-famous – St Mary’s Paddington with the private Lindo Wing, Hammersmith Hospital with the Robert and Lisa Sainsbury Wing, Charing Cross Hospital and The Thames View, The Western Eye Hospital and Queen Charlotte’s and Chelsea Hospital. globalopportunityhealthcare.com

Issue 01

| Global Opportunity Healthcare Private Patients 2016

93

The Lindo Wing

| The Lindo Wing at St Mary’s Hospital in London provides high quality care for complex cases, as well as unrivalled maternity services, says Sarah Cartledge

Tradition of excellence S

t Mary’s Hospital, part of Imperial College Healthcare NHS Trust, is the major acute hospital for northwest London as well as a maternity centre with consultant and midwife-led services. The hospital provides care across a wide range of specialties and runs one of four major trauma centres in London in addition to its 24/7 A&E department.

The private facility, the Lindo Wing, is well known for obstetrics and gynaecology and many international patients follow the example of Britain’s royal family and choose to have their babies born there. Also, more than 50 per cent of the services in the Wing are general, providing the highest quality of care for surgical, medical and obstetric patients. The unit specialises in a range of complex and robotic surgeries including trauma, weight loss, vascular, gynaecology, urology, ear, nose and throat, and general surgery.

For maternity patients there is also the extra reassurance of the neonatal unit. The team treats women who have had complications during their previous or current pregnancies, and newborns requiring specialist medical support. It can care

94

Global Opportunity Healthcare Private Patients 2016

| Issue 01

globalopportunityhealthcare.com

| for babies born as early as 23 weeks and has in-house scanning capabilities that cannot be found in most other hospitals. It pioneered the world’s first dedicated neonatal MRI scanner. Only a few hospitals worldwide carry this sophisticated technology with the proficiency to carry out noninvasive scans of newborns’ hearts, brains and other organs, to identify conditions and causes.

The Wing originally opened in 1937 and has since been updated to offer the most comprehensive modern facilities on site, including private outpatient facilities, dedicated operating theatres, modern, private en suite rooms and day case rooms.

Unrivalled expertise The Lindo Wing has access to more than 350 consultants who are part of the wider Imperial College Healthcare NHS Trust, covering every medical, diagnostic and surgical specialty. Imperial Private Healthcare consultants have enviable reputations across many disciplines including cancer, renal services, haematology, neurology, cardiovascular services and plastic surgery.

The theatres can take 10 small or intermediate cases each day or two major cases, depending

The Lindo Wing

on the situation. There is no anaesthetic room prior to procedures, so patients are able to walk into the theatre where they can meet the staff and be reassured they are in good hands, and there is also a three-bed dedicated recovery area.

Many patients, particularly maternity patients, come back to the Lindo Wing as a result of the impressive service and familiar surroundings. “It is always nice to welcome people back,” says lead nurse Paul Highton, a former matron and Darzi Fellow at Imperial College. “Many of the staff have been here for years and this provides a sense of continuity which is reassuring for the patients.”

Having the consultants on site is also an additional benefit. Consultants operate across the NHS, also working privately in the hospital. If a consultant chooses to undertake their private practice at one of the private facilities, such as the Lindo Wing, they are on site and available for their private patients, instead of being based remotely.

“Being able to offer our consultants the ability to do their private practice on site is a huge bonus,” says Jane Boyle, Head of Business Development at Imperial Private Healthcare. “It means they continue to have access to their wider expert team for both their NHS and private work. Ultimately it benefits both parties in a way that’s more than the sum of its parts.”

Long-standing traditions St Mary’s has a long history of innovation and research — penicillin was discovered there in 1928 — and the first robotic surgery to remove fibroids was performed on site in 2013. It’s for this reason that international work comprises at least a quarter of the hospital’s overall work, an estimated £10m business.

Many people come from the Middle East, as well as China, Russia, the Far East, Europe and North America.

Excellent services Hotel services are provided by a dedicated hotel services team. An extensive and nutritious menu caters for special dietary, cultural and religious requirements (including vegetarian, kosher and halal meals), all prepared in the Lindo Wing’s private kitchens.

“As a patient with Imperial Private Healthcare, you’ll experience the best of both worlds – worldclass consultants providing care in modern, private facilities, all within some of London’s most trusted NHS hospitals,” says Jane. “From diagnosis until discharge, every patient at Imperial Private Healthcare can be assured of the highest levels of discretion and care. Each of our hospitals offer the comfort and convenience of private en suite rooms, where our world-class consultants, working alongside our nursing and hotel services team, will be on hand to support patients throughout their recovery.”

Further information www.imperialprivatehealthcare.co.uk

globalopportunityhealthcare.com

Issue 01

| Global Opportunity Healthcare Private Patients 2016

95

Imperial Private Healthcare

|

Military injuries are complex and challenging, but they offer the opportunity to innovate, Mr Shehan Hettiaratchy, a Lead Surgeon at Imperial Private Healthcare tells Sarah Cartledge

Major trauma A

s one of the major UK trauma centres, specialities at St Mary’s Hospital include treatment for those patients with severe limb injuries. With expertise from orthopaedic surgeons and plastic surgeons who are used to dealing with people with limbthreatening injuries, Imperial Private Healthcare’s reconstructive surgery team cares for patients with life-changing injuries from war and crime. These typically include wounds from gunshots, blasts and land mines from conflict-torn countries such as Libya and Egypt.

Imperial Private Healthcare’s reconstructive surgery team is led by Mr Shehan Hettiaratchy, who has experience of dealing with battle wounds in countries such as Afghanistan, Chechnya, Kosovo, Georgia, the Balkans and Haiti for both charities and the military. An Oxford graduate who also trained in London, Birmingham and Australia, he spent six months working with the British army and understands the physical and psychological side to such grave injuries.

“These are really difficult injuries and very challenging for the patients, but we have a big organisation that can deal with all the issues,” says Mr Hettiaratchy.

“The trigger for our involvement in such issues

96

Global Opportunity Healthcare Private Patients 2016

| Issue 01

was the case of a 16 year old boy who had been blown up in the Libyan conflict in 2011. The Libyan government asked the NHS to care for 50 patients and they were flown to the UK for treatment.”

Abdul Malek El Hamdi was injured when a grenade he and a friend found at their school exploded. His friend died and Abdul had serious fragmentation injuries. “Abdul wasn’t able to be cared for properly in Libya. He arrived one night with a potentially life-threatening infection to his leg, so we took him straight to the operating theatre.”

At the moment the hospital has many patients from the Egyptian police force who have blast injuries. Countries such as Libya have a formalised path for evacuating injured citizens to the UK and do so because they do not have enough resources or the right expertise to deal with them in-country.

Unrivalled expertise Imperial Private Healthcare has a number of British military consultants working within the organisation who are able to evaluate whether Mr Hettiaratchy and his team can help someone. In the case of Egypt, the team will receive an initial referral from the Egyptian Military Office about a patient, but there can often be a delay in obtaining a visa for entry into the UK. “Obviously the first 24 hours of any injury

globalopportunityhealthcare.com

|

Imperial Private Healthcare

is the most critical time, but sometimes this visa process can take up to two weeks,” Mr Hettiaratchy says. “Although these delays change the clinical picture, we have a unit that includes plastic surgeons – two with military backgrounds – orthopaedic surgeons, microbiologists, prosthetic technicians and a psychologist, supported by related health professionals.

“We plan as a team. These injuries require joinedup decision-making between surgical, medical and psychological specialties. To be able to offer the best treatment for complex surgeries, you need those elements – plastic, skin and soft tissue surgical expertise, considerable experience with bones, and skin infection knowledge. Our patients have multi healthcare needs and we manage and integrate them all. Some patients, especially those requiring artificial limbs, spend many months in rehabilitation with us.”

Continuing care and research

SHEHAN HETTIARATCHY, MA(OXON), BM BCH, DM, FRCS(ENG), FRCS(PLAST) Shehan Hettiaratchy graduated as a doctor from Oxford University in 1994 with prizes in both medicine and surgery and a blue in boxing. He underwent basic surgical training in London teaching hospitals and obtained FRCS (Eng) in 1998.

Shehan carried out a 3 year research fellowship in hand transplantation at Massachusetts General Hospital, Harvard Medical School, for which he was awarded a Doctorate of Medicine by Oxford University, a Hunterian Professorship by the Royal College of Surgeons of England and the Pulvertaft Prize by the British Society of Surgery of the Hand. He has authored over 70 papers, 2 textbooks and numerous book chapters and is lead for trauma research at Imperial.

Shehan’s main clinical focus is on hand and wrist surgery and extremity reconstruction. He has particular expertise in hand injuries, reconstruction of complex upper and lower extremity injuries, nerve injuries, infective complications and elective hand surgery. He believes in putting his patients at the centre of all that he does and only accepting the best. He is experienced in the needs of high profile individuals, including professional sportsmen and women.

Reconstruction and rehabilitation is another main focus for Mr Hettiaratchy and his team to enable patients to have an optimum quality of life. One of the advantages of the Trust’s partnership with Imperial College London is that the team is able to research new treatments on site. Their tissue engineering studies could dramatically improve outcomes for patients who require prosthetic bones or surgery on skin cartilage, and researchers are also examining different ways of growing bone and artificial skin.

Throughout the world there are a limited number of places where surgeons have genuine expertise in these kinds of injuries, and the team is continually building its understanding of conflict injuries to improve outcomes for all its patients. The hospital has an on site limb fitting service and prosthetic service so patients with limb loss can be admitted and treated. Additionally there are multi-lingual surgeons among the team so patients can be treated in their own language or one they can understand, to help them understand their treatment and care.

Within the organisation there are surgeons from all the Middle East countries and there is experience of all the cultural sensitivities. Currently there is a Middle Eastern patient in the hospital who fell from a London balcony while visiting the UK, and he was fortunate enough to be admitted and treated by the team. The Lindo Wing has its own operating theatres so patients can be seen immediately, improving the chances of a better outcome and helping them deal immediately with a traumatic situation.

“One of the reasons the Trust embraced militaryrelated surgery is that our innovative treatment of these patients will benefit other private and NHS patients needing limb reconstruction,” says Mr Hettiaratchy. “These are complex cases that require forward-thinking solutions, and as a result we are able to deal with the most complex of surgeries.”

Further information www.imperialprivatehealthcare.co.uk

globalopportunityhealthcare.com

Issue 01

| Global Opportunity Healthcare Private Patients 2016

97

Hammersmith Hospital

|

Determined to raise the bar

With its history of clinical innovation and research spanning over 80 years, the Haematology Department at Imperial College Healthcare NHS Trust’s Hammersmith Hospital is unique in its innovative approach to specialist expert care, says Dr Jiri Pavlu, Consultant Haematologist at Hammersmith Hospital and Honorary Clinical Senior Lecturer at Imperial College London

98

Global Opportunity Healthcare Private Patients 2016

| Issue 01

globalopportunityhealthcare.com

|

Hammersmith Hospital

DR JIRI PAVLU Dr Jiri Pavlu is a consultant haematologist at Hammersmith Hospital and honorary clinical senior lecturer at Imperial College, London.

He has worked at Imperial College Healthcare NHS Trust for over a decade and is a specialist in haematopoietic cell transplantation and acute leukaemias. He graduated from the first faculty of medicine of Charles University in Prague in 1998. He carried out his research in molecular haematology at St George’s Hospital Medical School in London and completed his specialist haematology training in London on the Royal Free and Hammersmith rotation. He is a member of the Royal College of Physicians and a fellow of the Royal College of Pathologists.

Dr Pavlu is a principal investigator and subinvestigator of various clinical trials and an active member of the British Society of Blood and Marrow Transplantation (BSBMT) and European Group for Blood and Marrow Transplantation (EBMT).

I

mperial College Healthcare NHS Trust’s private facility at Hammersmith Hospital, The Robert and Lisa Sainsbury Wing, offers world class specialist care in one of the capital’s leading NHS teaching hospitals. The unit’s adult clinical haematology service, of which I am a member, enjoys an international reputation as a world leading centre for blood disorders, blood cancers, red blood cell diseases, as well as serious bleeding and clotting disorders.

Our partnership between Imperial College Healthcare NHS Trust and Imperial College London means that many of our world renowned consultants are leaders in their field. Our best scientists and academic clinicians work together wherever possible, taking advantage of the unique concentration of clinical and academic expertise at Hammersmith Hospital.

Research is the lifeblood of what we do in the unit – to improve upon and develop our world-leading treatments to create invaluable opportunities for our patients to access the very latest in clinical trials, research and ground breaking treatments. In much the same way we are able to attract the very best in consultant talent, with every patient assured that their care remains consistently excellent throughout the entirety of their stay with us.

History of innovation and research

Not long after its inception in 1934, the Department of Haematology and the Royal Postgraduate Medical School at the hospital had soon became a leading clinical and research centre in its own

globalopportunityhealthcare.com

Issue 01

| Global Opportunity Healthcare Private Patients 2016

99

Hammersmith Hospital

| right – not only in Britain but across the British Commonwealth at that time.

By 1977, following the tenure of worldrenowned British haematologist John Dacie at its helm, the department as quoted in the British Journal of Haematology; ‘had become a model for the training of haematologists internationally, combining laboratory and clinical aspects of the

‘Our unique concentration of specialists on site opens the possibility for those patients, who may have been previously deemed unfit for certain treatments, to access care from the hospital’s leading consultants.’

100

Global Opportunity Healthcare Private Patients 2016

| Issue 01

discipline and establishing specialised sections within the field.’ This model remains as pertinent today as ever before, with the unit attracting leading haematologists from around the world, with the standards and traditions of research at Hammersmith continuing to be a primary factor in people seeking treatment at the unit over other leading private facilities in the capital.

The Haematology Department has now made substantial contributions to the understanding of the biochemical, immunological and molecular basis of many different types of blood cancers through a continued commitment to ground-breaking research and clinical trials. Indeed a significant proportion of clinicians, including myself, who work in the department are nearly all employees or academics of Imperial College London – a leading global university ranked eighth in the world for its superlative standards of medical teaching and clinical research.

The inextricable link between research and ground-breaking treatment in the unit brings a host of benefits to patients, setting the hospital apart from other leading private healthcare facilities in the capital – some of which may not be equipped to

globalopportunityhealthcare.com

| offer the high levels of specialist care afforded by the unit’s multidisciplinary team. Today there are very few centres in the UK who would be able to safely perform the amount of transplants that we can do at Hammersmith Hospital.

Expert care around the clock Consultants are usually not risk averse in their clinical decision-making – in order to be a researcher you have to go down many different avenues before you achieve a breakthrough. But they are risk averse when it comes to making sure members of the surrounding clinical infrastructure are at the top of their game. If a patient requires a kidney support for example, a private facility may often not have that crucial renal infrastructure. And if the consultant is only there for half of the week, the risks to the patient are too great given the lack of specific supportive clinical infrastructure.

Hammersmith Hospital

This is why our centre at Hammersmith is unique.

Although other private hospitals or private patient units across the UK house some exceptionally talented clinicians, the medical infrastructure is just not currently at the level that we need (and have come to expect at Imperial) to treat our patients - many of whom are often suffering from very serious medical conditions. Standard cover from a normal RMO (Resident Medical Officer) may often not be adequate following complex treatments or procedures. Our patients may require round the clock care from our expert specialists.

For example, should the unit perform a stomach biopsy on a Friday, the relevant consultant will expect over the following weekend to have a senior doctor available on call. With our large medical unit on site, we are able to roster a senior clinician to be on call, as well as a team of specialist nurses and support staff.

Access to the latest treatments

‘The Haematology Department has now made substantial contributions to the understanding of the biochemical, immunological and molecular basis of many different types of blood cancers through a continued commitment to ground-breaking research and clinical trials.’

Our unique concentration of specialists on site opens the possibility for those patients, who may have been previously deemed unfit for certain treatments, to access care from the hospital’s leading consultants.

A notable example from our haematology department involved a private patient from Germany who was presented to the Hospital for treatment of relapsed acute myeloid leukaemia.

Before he approached us, the patient had been turned down for treatment at another centre for being too old and frail to survive treatment. But under our expert care he performed very well during and after treatment, living for many years after the publication of his case. This is one of many positive outcomes that we continue to be extremely proud of.

The unit’s skillset in diagnosis and therapy for many other rare blood disorders, including thalassaemia major, is also very relevant for those patients coming to us from the Middle East – due to consanguinity (genetic links through kinship).

Recent examples include two families from Turkey and the UAE who were referred to one of the unit’s leading consultant haematologists, Dr Mark Layton.

Working in partnership with his colleagues, he was able to describe a completely new disease, with a newer and more effective treatment plan initiated upon the results of the team’s work.

Extremely successful outcomes such as this are largely unique to a leading NHS teaching hospital like Hammersmith – the support, concentration of expertise and a continuous commitment to advancing the most effective treatments for a variety of rare diseases remains pivotal to the unit’s continued success as a world leader in specialist care.

Further information www.imperialprivatehealthcare.co.uk

globalopportunityhealthcare.com

Issue 01

| Global Opportunity Healthcare Private Patients 2016

101

Professor Christina Fotopoulou

| Consultant gynaecological oncologist at Queen Charlotte’s and Chelsea Hospital London, Professor Christina Fotopoulou talks about combining surgical expertise with pioneering research into highly specialised cancer treatment

Advanced gynaecological surgery 102

Global Opportunity Healthcare Private Patients 2016

| Issue 01

globalopportunityhealthcare.com/private patients

|

Professor Christina Fotopoulou PROFESSOR CHRISTINA FOTOPOULOU

A

t Hammersmith Hospital we treat people from all over the world including Europe and the USA, and I have referrals from the private sector as well as NHS patients. My main area of expertise is in advanced forms of gynecological cancer.

Ovarian cancer, the main cause of death from gynaecological cancer, is often diagnosed late, but it is rarely too late for something to be done. Up to 70-80 per cent of patients with ovarian cancer will present symptoms at a late stage three or four. But in spite of such, ovarian cancer is one of the few cancers that can still be operated on even if the disease has spread. The problem of late diagnosis lies in the fact that symptoms are rather not specific, and include abdominal bloating, pain and bowel problems that may be diagnosed by a GP as IBS. An average GP will usually see one ovarian cancer case every five years, and the art is to identify that patient.

With surgery a patient’s chance of survival can be increased signifcantly, and a patient who has undergone radical surgery that resulted in complete tumour clearance will have a better survival rate than someone who has not had surgery or had residual postoperative disease. There are even some patients– about 17 per cent across all types of patients in stages IIb to IV - who can be cured. I am still contacted by people I operated on in Germany some years ago who get in touch to tell me they are doing well, or ask me to go back and operate again due to a late relapse.

The average age of a patient who develops ovarian cancer is around 65 years but in a centre like ours we see also much younger patients.

The importance of research

IMAGE: WWW.SHUTTERSTOCK.COM

We are conducting important research here at Hammersmith, which we carry out alongside the surgery. We have a large research facility on site as well as a big tissue collection database. At Imperial the Healthcare NHS Trust and the University work in close partnership, so this arrangement is ideal for patients with complex conditions who require pioneering surgery and treatment.

Our research projects include the better understanding of the profile of the tumour and the correlation of the tumour biology to clinical and surgical characteristics. Furthermore, we strive to implement novel and pioneering technology such

globalopportunityhealthcare.com

Professor Christina Fotopoulou is a consultant gynaecological oncologist at Queen Charlotte’s and Chelsea Hospital in Imperial College London.

She was trained in obstetrics and gynaecology at the Charité University Hospital of Berlin in Germany with a sub-specialisation in gynaecological oncology. Professor Fotopoulou was the leading consultant and Vice Director of the Department for Gynecology at the Charité in Berlin, one of the largest accredited centres for gynaecological cancer in Europe.

She has also been the principal coordinator of the European Competence Centre for Ovarian Cancer, which was created in 2007 in Berlin. Her principal area of expertise relates to radical and exenterative surgery for primary and relapsed ovarian cancer but also any forms of advanced gynaecological cancer.

She is also trained in reconstructive techniques after cancer surgery. Among her research projects she has investigated the implementation of targeted therapies in advanced gynaecological cancers and the implications of novel technology and bioengineering on surgical practice.

She has broad experience in national and international clinical and surgical trials in gynaecological cancers and is involved in the German, British and European committees for guidelines development in ovarian cancer and in various national and international consortia. She has been the author and editor of numerous book chapters and articles about gynaecological cancer.

as bioengineering into clinical practice for the maximum benefit of the patients.

Every patient with ovarian cancer is unique and for that reason our aim is to treat every woman in an individual way according to her needs and preferences, but also to the profile that her tumour presents. I have had many patients come to me because they have read my research, which they have said is a significant marker of excellence.

Expertise I am a specialist in radical surgery for advanced forms of gynecological cancer and strive always for the best for my patients. However, the whole team contributes to the wellbeing of the patient to achieve optimal outcomes. I only operate in Hammersmith Hospital because every part of the team – every scrub nurse knows what I need and what the patients need. The whole philosophy of fitting the operating theatre to the needs of each specific patient is clearly understood.

We are all one team undertaking this difficult surgery to ensure the best possible outcomes.

Further information www.imperialprivatehealthcare.co.uk

Issue 01

| Global Opportunity Healthcare Private Patients 2016

103

Charing Cross Hospital

|

Luxury bespoke care from world-class consultants in one of the UK’s top teaching hospitals makes Imperial College Healthcare NHS Trust’s private facility ‘The Thames View’ at Charing Cross Hospital truly unique, as Matt Williams, Consultant Clinical Oncologist, tells Jack Ball

A worldclass team for complex problems

A

s part of Imperial College Healthcare NHS Trust, Charing Cross Hospital located in Hammersmith, West London is universally regarded as a leading centre for neurosciences, neuro-rehabilitation, complex surgery, elective orthopaedics and cancer care.

With spectacular views over London that rival some of the capital’s most luxurious hotels, and located less than 15 minutes from central London by train, the Trust’s private patients facility ‘The Thames View’ at Charing Cross Hospital is a home away from home like no other. Located at the very top of the hospital on the 15th floor, the newly refurbished unit offers unrivalled access to the Trust’s internationally renowned consultants in one of London’s most trusted teaching hospitals – using the latest approaches to tackle a range of complex clinical problems.

“If you’ve got something that’s difficult and complicated, Imperial Private Healthcare offers a service that’s difficult for other people to replicate,” says Matt Williams, consultant clinical oncologist based at Charing Cross Hospital. “This is simply because we have so many high level resources on hand.”

And with the Trust’s partnership with Imperial College London, many consultants are involved in the most cutting-edge clinical research, allowing the most up to date treatment for all Thames View patients.

World leading neuro-oncology team

The facility’s multidisciplinary team (MDT) approach is continuing to set the standard nationally, as the Trust brings together its wealth of clinical expertise and medical technology to ensure the highest levels of comprehensive and holistic care.

104

Global Opportunity Healthcare Private Patients 2016

| Issue 01

globalopportunityhealthcare.com

|

globalopportunityhealthcare.com

Issue 01

Charing Cross Hospital

| Global Opportunity Healthcare Private Patients 2016

105

Charing Cross Hospital

|

DR MATT WILLIAMS Dr Matt Williams is a Consultant Oncologist specialising in the treatment of brain and spinal tumours.

He undertook his oncology training across London, and was awarded his PhD from University College London in 2009. He spends approximately a third of his time engaged in research, and leads the Computational Oncology research group at Imperial College.

Dr Williams completed his undergraduate studies in Birmingham, before moving to London where he worked as a senior house officer at Hammersmith Hospital. He then ran an A&E department in The Gambia for a year, in the capital’s main hospital. Upon returning to the UK he completed his clinical oncology training in London, followed by a PhD with the Advanced Computation Lab at CRUK/UCL. He specialises in brain and central nervous system tumours, skin cancer and palliative radiotherapy. He was appointed as a consultant and honorary senior lecturer at Imperial College Healthcare NHS Trust in February 2012.

Their world-class neuro-oncology team, of which Matt is a member, exemplifies how an MDT approach to complex issues can achieve the best possible clinical outcomes. But only if they are done properly. “We have weekly MDT meetings where we discuss all of the NHS and private brain tumour patients. You have to remember that Imperial is a big hospital where many leading clinicians work.”

“The advantage of the multidisciplinary approach at Charing Cross is that all of the neurosurgery and all of the oncology are all in the same physical location - in the same hospital. I can very easily go onto the ward or speak to a colleague of a different specialism if need be. So it is very easy to provide that very detailed input with continuous interaction between the specialties.”

Although Matt doesn’t go into theatre, he works extremely closely with other specialists. For example, once a specific consultant surgeon has identified an issue during surgery, the whole team is then able to make decisions in an MDT meeting over the best course of treatment – this bespoke treatment plan is offered to all patients.

“We expect to discuss all private patients being treated here - this allows input from oncologists, surgeons and researchers and so on.”

And with the Trust’s specialties spread over the five different sites, expertise is actively shared among all clinicians - this is particularly important for those patients experiencing a multitude of complex problems.

“We are all part of the same Trust,” explains Matt. “And one of the crucial benefits of Imperial is that we have access to an extremely wide range of specialists across several different clinical domains. We can bring doctors over from other sites if patients require treatment for more than

106

Global Opportunity Healthcare Private Patients 2016

| Issue 01

Above: ‘The Thames View’ at Charing Cross Hospital, located at the very top of the hospital on the 15th floor Right: Maggie’s Cancer Caring Centre located at the Charing Cross Hospital

one issue. For example, Hammersmith Hospital specialises in expert liver treatment. So when I was treating a woman with a brain tumour and various liver problems here at Charing Cross hospital, we were able to bring in specialist liver doctors from Hammersmith during her stay with us - this actually happens reasonably often.

“Our clinical notes are also electronically stored on the same computer systems, so it’s incredibly easy to talk to another member of the team on a different site straight away.”

And Imperial’s unique multidisciplinary approach to clinical care is also having implications far wider than its immediate catchment area of West London.

Matt’s leading work as part of the Trust’s specialist Brain Tumour Service is testament to their pioneering work in successfully treating those with complex and life-threatening brain tumours.

“The service serves a population of just over two million people. But we attract significant numbers of referrals from other parts of the UK - people come and see us from all over the country for second and third opinions.”

globalopportunityhealthcare.com

|

Charing Cross Hospital

Unrivalled luxury Complementing the exceptional levels of clinical care on hand is the luxury accommodation offered at The Thames View. Similar to any top private hospital in the UK, amenities on hand include daily newspapers, complimentary toiletries and free wifi. Overseas patients can also expect additional services such as translators, foreign-language newspapers and a multi-faith worship room.

This year also saw an extensive refurbishment of all accommodation facilities with all rooms fitted with contemporary hotel-style en-suite bathrooms compete with new walk-in showers. Bedrooms have been fully refurbished with improved air-conditioning so patients can enjoy the most optimal temperatures all year round.

Head of Programmes, Louise McCarthy says; “We have successfully scheduled this upgrade to ensure minimal disruption to patients and clinical staff. And we are absolutely delighted with the results.”

Academic partnership

IMAGES: WWW.SHUTTERSTOCK.COM

Currently ranked eighth in the world1, Imperial College London enjoys a unique partnership with the Trust. The Charing Cross campus, as part of the University’s Faculty of Medicine, is a hub for medical teaching and research.

“I teach some undergraduates and run the computational oncology lab at Imperial,” Matt explains. “I’m in the process of developing an online system where we can get patients to record their quality of life, gathering data for cancer patients.

“I have also set up and run the country’s first neuro-oncology Skype clinic – this means that patients do not have to physically come and see our consultants.” In terms of follow up care for overseas patients at Imperial, the Skype Clinic is proving particularly useful. “Although people may need scans which can’t be done via Skype, we can still assess how they are and give them the scans later – a hybrid model.”

An unparalleled level of comfort offered at Thames View and the Trust’s multidisciplinary approach from the hospital’s leading consultants in their field means every patient can be assured of the highest levels of individually tailored care.

In short, Imperial’s private offering in the form of Thames View brings three unique benefits - medical technology and specialist facilities on site 24 hours a day delivered by Imperial College Healthcare NHS Trust’s internationally renowned consultants, in one of the capital’s most luxurious clinical environments.

“We give access to an enormous range of specialties,” says Williams. “We offer lots of different treatments for lots of different diseases. It’s rare there aren’t many places that can do that.”

2016 QS World Rankings – www.topuniversities.com/universities/ imperial-college-london 1

Further information www.imperialprivatehealthcare.co.uk

globalopportunityhealthcare.com

Issue 01

| Global Opportunity Healthcare Private Patients 2016

107

Charing Cross Hospital

|

Leading the charge Kevin O’Neill, Head of Neurosurgery at Imperial College Healthcare NHS Trust, talks exclusively to Jack Ball about the Trust’s pioneering research into developing and integrating the very latest in advanced surgical technologies

W

ith the Thames View located in one of the UK’s top NHS teaching hospitals, the clinical expertise, research and world-class medical technology on offer at Imperial Private Healthcare at Charing Cross Hospital is unparalleled in its breadth.

The facility’s partnership with Imperial College London means leading consultants at The Thames View have access to the very latest in clinical trials, academic and multidisciplinary research. The resulting innovative approaches can be translated directly into the clinical setting – giving hope to thousands of patients living with complex brain tumours looking to Imperial Private Healthcare for the very best in private care.

“I want to be actively involved in making things better for all our patients through research,” says Kevin O’Neill, consultant neurosurgeon at the Thames View and Head of Neurosurgery at Charing Cross Hospital. “At Imperial Private Healthcare we get access to the complete range of NHS support systems already in place, including our intensive care services and all of the sub-specialities which are always available for input when needed. All treatments on offer are kept as up to date as possible through this unique NHS framework with a solid commitment to clinical progress and research.”

Research and development Partnership between the Trust and Imperial College London, one of the world’s leading medical research universities, means treatments for all brain tumour patients at the Thames View have the full support

108

Global Opportunity Healthcare Private Patients 2016

| Issue 01

DR KEVIN O’NEILL Kevin is a consultant neurosurgeon and Head of Neurosurgery at Charing Cross Hospital. Having gained his neurosurgical training at Atkinson Morley’s Hospital, Great Ormond Street Hospital and the National Hospital for Neurology and Neurosurgery in Queen Square. During this time he was Chairman of the British Neurosurgical Trainees Association. He is now practicing general neurosurgery at Charing Cross, although most of his elective practice consists of spinal and peripheral nerve surgery.

He is also the designated neurovascular surgeon dealing with all subarachnoid haemorrhage patients and complex brain and spinal vascular conditions. His research interests include Brain Tumour Invasion and he is heavily involved in research into novel treatments.

globalopportunityhealthcare.com

|

globalopportunityhealthcare.com

to further understanding the ‘molecular makeup’ of malignant tumours – to establish what goes wrong, when and where, and to use such information to find easy paths to newer and more effective treatments.

Only an advanced healthcare facility like Charing Cross Hospital, with its enviable status as a leading London NHS teaching hospital, makes such innovative research viable within the clinical setting.

“We have to make sure that we understand and coordinate the correct direction of resources. This requires proper management of all the expertise to hand,” says Kevin. “So I try to develop a process – to look at every single step that a patient follows and gather information from all our different expert specialities.”

This interdisciplinary approach between specialities ensures every patient treated at the Thames View has immediate access to the most upto-date treatments using the very latest innovations in the field of clinical technology.

Issue 01

| Global Opportunity Healthcare Private Patients 2016

109

IMAGE: WWW.SHUTTERSTOCK.COM

of the University’s world-class academic community.

Kevin is keen to stress the inextricable link between the clinical research undertaken at Imperial College London and the latest treatments offered from Imperial’s multidisciplinary neuro-oncological teams.

One recent avenue of research for Kevin involves the computational analysis of tumour growth to determine the most effective course of treatment.

“When a genetic code goes wrong, tissues become tumours,” he explains. “This code is similar to that of a computer. So we can actually undertake computational analysis of a malignancy to work out where the code differs from those found in normal tissues. We can then use this information to see which drugs already on the market will be most effective in redressing these potentially dangerous genetic imbalances.”

Kevin currently works within Imperial College’s large molecular lab, alongside many different collaborators within the Trust who are committed

Charing Cross Hospital

Charing Cross Hospital

|

Charing Cross Hospital

|

‘We strive to make what we already do as good as possible through a continuous process of translation and research – the key is to choose a facility like Imperial at Charing Cross that has those unique levels of energy and drive from a multitude of specialities.’

“It’s about building a platform that gives every patient the opportunity to access the best possible treatment,” explains Kevin. “We can potentially introduce patients into a new trial or a study that they may want to participate in, as well giving access to the latest surgical approaches.”

Continuous clinical innovation Biopsies are crucial during surgery and are critical during neurosurgery, with cancerous tissue looking and behaving similarly to that of healthy brain matter. As such, accurate assessment of which tissues need to be removed can often be a difficult and painstaking process, even for the most advanced surgeon.

Developed by Professor Takats of Imperial College London, the iKnife offers immediate biopsy testing during surgery. Kevin explains its technology; “This device cauterises tissue during surgery to produce smoke which is then analysed using a mass spectrometer – the charged particles in the smoke are able to give a molecular fingerprint of the tissue being operated on.”

Not only can Kevin and his team use this ‘molecular footprint’ to remove malignant tissue in real time, but they can also establish the most effective treatment options in the fastest possible time.

Fibre optic technology By its very nature, neurosurgery is an extremely delicate undertaking – optimal efficiency and clinical safety remains paramount so as not to damage or remove surrounding healthy tissues that may be critical for normal cognitive function.

110

Global Opportunity Healthcare Private Patients 2016

| Issue 01

Part-funded by the charity Brain Tumour Research Campaign, an Imperial trial in 2015 opened the door for the next generation of infrared technology to be used in neurosurgery to identify malignant tissue, without the need to cauterise tissue. First developed in Canada for use in skin-cancer surgery, ‘the core’ uses a near-infrared probe to shine a beam of light onto the exposed brain. As the healthy and unhealthy tissues scatter light differently, surgeons can immediately identify malignant tissue without cauterising any potentially healthy tissue.

As quoted by the BBC, following its pioneering use in brain surgery at Charing Cross Hospital in August 2015, colleague and fellow neurosurgeon Babar Vaqas said; “Optical technologies are the future. They are fast and don’t destroy any tissue and could be used during many types of cancer surgery or when dealing with infection like a brain abscess.”

Kevin and his team are also working on a similar type of technology using a single spot of blood to gather a molecular fingerprint. “This technique can help establish whether a patient has a tumour, the nature of a malignancy and how the patient is responding to treatment.”

This next generation of technology spearheaded for use by consultants at Imperial Private Healthcare is only made possible by the extensive research programmes available through the NHS. “A major advantage of Imperial Private Healthcare at Charing Cross is our thorough commitment to progressive medicine, combined with the personalised and individualised attention of the private sector,” explains O’Neill.

“We strive to make what we already do as good as possible through a continuous process of translation and research – the key is to choose a facility like Imperial Private Healthcare at Charing Cross that has those unique levels of energy and drive from a multitude of specialities.”

Further information www.imperialprivatehealthcare.co.uk

globalopportunityhealthcare.com

Great Ormond Street Hospital for Children • One of the top four paediatric research hospitals in the world.

• Through pioneering translational research, Great Ormond Street Hospital (GOSH) provides cutting-edge treatment for the rarest and most complex paediatric conditions.

• Over 50 clinical specialities and 300 world-class consultants under one roof.

• A dedicated and tailored service for international patients, including a multi-lingual patient support team.

• Central London location.

GOSH Global View the extensive list of consultants and specialities available through our new app.

Search for ‘GOSH Global’ in your app store now.

For more information or to refer a patient to Great Ormond Street Hospital for Children, please get in touch.

Download the GOSH app today

The Harris International Patients Centre The Octav Botnar Wing Great Ormond Street, London, WC1N 3JN +44 (0)20 7762 6822 privateinfo@gosh.nhs.uk | www.gosh.com.kw